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In this thesis I have employed multiple in vitro models at both cellular and molecular 
levels to investigate a possible transmitter role for extracellular ATP in the 
neuroendocrine system. 
ATP induced a rapid increase in [Ca2+]; in a subset of cultured rat hypothalamic 
neurons. This intracellular Ca2+ response was highly specific and mediated by ATP 
receptors of the P2X subtype, activation of which was independent of ATP hydrolysis 
and resulted in influx of Ca2+ largely through `L' type voltage-gated Ca2+ channels. 
ATP also caused intracellular Ca2+ responses in approximately 30% of rat pituitary cells 
in primary culture. The studies have firmly established the gonadotrope as one of direct 
target cells for ATP via a single class of receptor characterized as the P2U subtype of 
ATP receptor. Activation of this receptor had no apparent effects on the cAMP and 
cGMP signalling systems but produced a biphasic cytosolic Ca2+ increase by 
mobilizing intracellular Ca2+ from gonadotropin releasing hormone- and thapsigargin- 
sensitive Ca2+ pools and stimulating Ca2+ influx through `L' type voltage-sensitive 
Ca2+ channels. This Ca2+ response was mediated by a pertussis toxin-insensitive and 
phospholipase C-coupled G-protein. Agonist occupancy of this receptor caused 
translocation of protein kinase C (of the isozyme e in (M-1 cells) and a significant 
release of luteinizing hormone from superfused rat pituitary cells. 
The present data have further revealed that substantial amount of ATP can be 
exocytotically released from pituitary cells, implying a possible paracrine and/or 
autocrine mechanism by which the extracellular nucleotides may exert their effects on 
pituitary cells. 
In conclusion, this'thesis provides strong evidence for a novel mediator role for ATP 
receptors in the neuroendocrine - and particularly in gonadotrope - function. 
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PREFACE 
This dissertation describes studies which were designed to examine whether 
extracellular ATP could play a special role as a transmitter in hypothalamic neurons and 
pituitary cells. The subject was initiated by the suggestion that extracellular ATP, acting 
on ATP receptors (P2 purinoceptors), could be a neurotransmitter in both peripheral 
and central nervous systems. 
It is just within the last few years that information about ATP receptors has dramatically 
expanded and this has led to the field being widely recognized. An overview of our 
current understanding of ATP receptors is, therefore, provided first in this dissertation 
to serve as an introduction to the field. What has been gained from my studies is then 
summarized in such way that each piece of work is presented with its own integrity 
including rationale, methods, results and discussion. For simplicity, the general details 
of all methods used are given in one section (Chapter 2). 
16 
Chapter 1. AN OVERVIEW OF ATP RECEPTORS 
In 1929 Drury and Szent-Gyorgyi (1929) published the first report that adenylic acid 
and adenosine produced sinus bradycardia, complete atrioventricular block, a negative 
inotropic effect on the atrium and cessation of atrial fibrillation in the mammalian heart. 
In 1933 Gillespie (1933) found that ATP had an inotropic effect in frogs and Drury in 
1936 suggested that ATP and adenosine might have different effects on cardiac 
contraction. Holton et al in 1950s demonstrated that ATP was present in dry powders 
of spinal roots (Holton & Holton 1954) and in the perfusate of the rabbit ear artery 
following nerve stimulation (Holton 1959), hinting a possible neurotransmitter role for 
ATP. It was almost a decade, however, before Burnstock and his colleagues observed 
a non-adrenergic and non-cholinergic element in the autonomic nervous system, and 
made the landmark proposals that ATP acted as a neurotransmitter in the peripheral 
autonomic nerves (Burnstock et al. 1970, Burnstock 1972, Burnstock et al. 1972, 
Burnstock 1976). This finding was confirmed and extended over the subsequent two 
decades, with ATP-evoked synaptic potentials being recorded between neurons in the 
central and peripheral systems (Edwards et al. 1992, Evans et al. 1992, Silinsky et 
al. 1992). The very recent molecular cloning of P2 purinoceptors removed the last 
doubts about nucleotides being true extracellular mediators (Lustig et al. '1993, Webb 
et al. 1993, Brake et al. 1994, Valera et al. 1994), and it is now clear that Al? is a 
ubiquitous extracellular mediator acting on a superfamily of P2 purinoceptors that may 
play important physiological and pathophysiological roles in a variety of biological 
processes including neurotransmission, platelet aggregation, muscle contraction and 
relaxation, secretion of insulin and surfactant, immune response and cell growth. 
This review will mainly focus on the most recent advancements in this rapidly 
expanding field with an emphasis on Al? receptors in the central nervous system. 
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1.1 P2 Purinoceptor Family 
The receptors for purine compounds, purinergic receptors, constitute a large and 
diverse family that are expressed in a very wide range of tissues. In 1978, Burnstock 
proposed a basis for two types of purinergic receptor and subgrouped into Pl and P2 
purinoceptors. Pl receptors were preferentially activated by adenosine, while P2 by 
ATP. This classification was widely adopted and extended. Adenosine receptors (P1 
purinoceptors) have been further classified into Al, A2 and A3 (Fredholm et al. 1994). 
Correspondingly, ATP receptors (P2 purinoceptors) were subdivided in 1985 by 
Burnstock and Kennedy into P2X and P2Y on the basis of rank-order of agonist's 
potency: - for P2X, this was a, ß-methylene ATP z ß, rmethylene ATP > ATP = ADP > 
2-methylthioATP with selective desensitization by a, p-methylene ATP; and for P2y, 2- 
methylthioATP » ATP » a, ß-methylene ATP = p, rmethylene ATP. This proposal 
was later found to correlate with receptor signal transduction mechanisms: - the P2X 
being ligand-gated ion channels and the P2 G protein-coupled receptors. In 1986, 
Gordon added two additional P2 purinoceptors into this scheme since the nucleotide 
receptors in platelets and immune cells did not fit very well into either the P2X or P2Y 
subtype. In platelets, ADP is the most potent agonist and ATP acts as an antagonist 
(termed P2T), while in immune cells the most potent agonist is the fully ionized form of 
ATP (ATP4-) (termed Pu). In some cell types, UTP has been found to be equipotent or 
even more potent than ATP, and the corresponding receptor was tentatively termed 
"nucleotide receptor" (Davidson et al. 1990) (which was consequently adopted by 
O'Connor et al. (1991) or re-termed P2U receptor (Dubyak 1991). There is also 
evidence for purinoceptors that preferentially respond to adenine dinucleotide 
polyphosphates (ApxA) - P2D receptors (Hilderman et al. 1991, Castro et al. 1992). 
An overview of P2 purinoceptor is shown in Table 1-1. 
P2X purinoceptors 
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Edwards & Gibb 1993). The channels in the different cell types appear to be similar but 
not identical in their ligand selectivity and their ion permeability, indicating the existence 
of multiple subtypes. This has been clearly demonstrated by the recent cloning of two 
distinct ATP-gated ionotropic receptors (Valera et al. 1994, Brake et aL 1994). 
Although P2X purinoceptors have been reported to be present in lacrimal cells (Sasaki & 
Gallacher 1992, Vincent 1992) and microglial cells (NÖrenberg et al. 1994, Langosch 
et al. 1994), they are predominantly confined to muscles and neurons. The former 
includes cardiac muscle (Friel & Bean 1988, Danziger et al. 1988, Scamps & Vassort 
1990, Alvarez et al. 1990, Christie et al. 1992), skeletal muscle (Kolb & Wakelam 
1983, Thomas & Hume 1990, Thomas et al. 1991) and smooth muscle such as 
vascular (Benham et al. 1987, Benham & Tsien 1987, Burnstock & Warland 1987, 
Ziganshin et al. 1994), bladder (Moss & Burnstock 1985, Inoue & Brading 1990, 
Schneider et al. 1991, Ziganshin et al. 1993) and vas deferens (Friel 1988, Bo et al. 
1992). The latter includes both peripheral nerve cells such as sensory neurons (Krishtal 
et al. 1983, Bean 1990), dorsal horn neurons (Jahr & Jessell 1983), celiac neurons 
(Evans et al. 1992, Silinsky et al. 1992), parasympathetic neurons (Fieber & Adams 
1991) and intracardiac neurons (Allen & Burnstock 1990) and central neurons 
(described later in this chapter). 
PZY purinoceptors 
P2Y purinoceptors belong to G protein-coupled membrane receptors, activation of 
which causes an increase in phospholipid turnover and intracellular Ca2+ (Ca2+; ) 
mobilization, presumably resulted from activation of phospholipase C (PLC). 
Burnstock's original classification criteria based on the agonist profile of 2- 
methylthioATP > ATP » a, ß-methylene ATP, p, r-methylene ATP is still widely used 
for definition of this receptor (Burnstock & Kennedy 1985). P2Y receptors have a wide 
tissue distribution and has been found in erythrocytes (Berrie et al. 1989, Boyer et aL 
1989), leukemic basophils (Osipchuk & Cahalan 1992), pancreatic ß-cells (Gylfe & 
20 
Hellman 1987), endothelial cells (Boeynaems & Pearson 1990), hepatocytes (Dixon et 
at. 1990, Keppens 1993), astrocytes (Pearce et al. 1989) and brain tissue (Webb et 
al. 1993, von Kugelgen et al. 1994). 
P2U purinoceptors 
P2U purinoceptors also belong to G protein-coupled membrane receptors and have a 
wide tissue distribution as does the P2Y purinoceptor. Cells having been reported to 
possess P2U receptors include neutrophils (Axtel et al. 1990, Kuroki & Minakami 
1989), monocytes (Cowen et al. 1989), macrophages (Greenberg et al. 1988, 
Pfeilschifter et al. 1989), HL-60 promyelocytes (Dubyak et al. 1988, Stutchfield & 
Cockcroft 1990), osteoblast (Reimer & Dixon 1992), keratinocytes (Pillai & Bikle 
1992), pituitary cells (Davidson et al. 1990, Chen et al. 1994b, Carew et al. 1994), 
FRTL-5 thyroid (Okajima et al. 1989, Sato et al. 1992), endothelial cells (Lustig et 
al. 1992, Purkiss et al. 1993), fibroblasts (Fine et al. 1989), hepatocytes (Dixon et 
al. 1990, Keppens 1993), PC12 cells (Murrin & Boarder 1992), chromaffin cell (Kim 
er al. 1990), airway epithelial cells (Brown et al. 1991, Parr et al. 1994), mesangial 
cells (Pfeilschifter 1990), amnion cells (Vander Kooy et al. 1989), aortic vascular 
muscle (Tawada et al. 1987) and Erhlich ascites tumor cells (Dubyak 1986). 
There is some evidence to suggest that UTP and ATP act on different receptors. For 
example, in perfused rat liver, ATP and UTP produced differential actions on portal 
pressure, glucose output, K+ uptake and Ca2+ release (Haussinger et al. 1987). 
Differentiation of HL60 cells altered the response to UTP but not ATP (Stutchfield & 
Cockcroft 1990). a, p-methylene ATP desensitized more to ATP than to UTP in 
vasoconstriction of rabbit ear artery (von Kugelgen et al. 1987). Pertussis toxin (PTX) 
and adenylate cyclase activators blocked the activation of p-nicotinamide-adenine 
dinucleotide phosphate (NADPH) oxidase by UTP but not by ATP in human neutrophil 
and HL-60 leukaemic cells (Seifert et al. 1989). Pyridoxalphosphate-6-azophenyl- 
2', 4'-disulphonic acid (PPADS) selectively antagonized a, ß-methylene ATP- but not 
21 
UTP-evoked depolarization in the rat superior cervical ganglion (Connolly 1994). In 
contrast, many other cells or tissues have been shown to exhibit cross desensitization 
between ATP and UTP to suggest the responses are mediated by a common nucleotide 
receptor that recognizes both ATP and UTP (Pfeilschifter 1990, Brown et al. 1991, 
Iredale et al. 1992a, Chen et al. 1994c), perhaps at distinct binding sites (Erb et al. 
1993). 
P2D purinoceptors 
The existence of P2D purinoceptors have been demonstrated by specific binding sites 
for [3H]-Ap4A in cultured chromaffin cells (Pintor et al. 1991) and rat brain 
synaptosomes (Pintor et al. 1993). This is strengthened by the studies using a 
monoclonal antibody (against a putative Ap4A receptor) which bound to the mouse 
heart cell surface and inhibited the [3H]-Ap4A binding (Walker et al. 1993). To date, it 
appears that all diadenosine polyphosphates (Ap3A, Ap4A, Ap5A and Ap6A) act on a 
single class membrane receptors (Pintor et al. 1991, Hilderman et al. 1994) and that 
the corresponding binding sites are found in heart, fat, brain, muscle, liver, spleen and 
kidney (Hilderman et al. 1991). Some cells such as cortical neurons (Stone & Perkins 
1981), brain synaptosomes (Pintor et al. 1993), chromaffin cells (Pintor et al. 1991), 
heart cells (Walker et al. 1993) and platelets (Zamecnik et al. 1992) have been 
reported as direct targets for adenine dinucleotide polyphosphates. 
P2T purinoceptors 
P2T purinoceptors are thought to be confined to platelets (Gordon 1986) but recent 
evidence seems to suggest that they exist elsewhere, such as in brain capillary 
endothelial cells (Frelin et al. 1993, Vigne et al. 1994), K562 leukaemia cells (Murgo 
& Sistare 1992), megakaryocytic Dami cells (a human megakaryocytic leukaemia cell 
line) (Murgo et al. 1994) and UMR- 106 osteoblasts (Sistare et aL 1994). 
22 
P2Z purinoceptors 
P2Z purinoceptors appear to be expressed exclusively in immune cells, though the 
pharmacological data of P2 purinoceptor in rat parotid acinar cells (McMillian et al. 
1988, Tenneti & Talamo 1993) are also indicative of the P2z subtype. The structure of 
P2 purinoceptor is poorly understood. Some evidence indicates that the P2Z receptors 
in macrophages are coupled to a cation channel, in addition to being non-selective 
membrane pores (permeable to molecules with Mr up to about 900 and its formation 
being both time- and temperature-dependent) (Nuttle & Dubyak 1994). It has even been 
suggested that the gap junction protein connexin-43 in mouse macrophages is the P2Z 
receptor on the basis that the macrophage expresses the connexin-43 mRNA/protein 
and that the property of ATP-induced pores is similar to that for gap junctions (Beyer & 
Steinberg 1991). 
Other nucleodde receptors 
Recent data appear to indicate the existence of novel groups of receptors for guanine 
and uridine compounds, respectively. In rat mesenteric artery, GTP and guanosine (10 
pM -1 mM) induced both endothelium-dependent and -independent relaxations, which 
were not affected by 8-phenyltheophylline and reactive blue 2 (Vuorinen et al. 1994). 
PLC in the rat glioma cell line C6-2B was activated by UTP or UDP but not by ATP, 
ADP and other analogues (Lazarowski & Harden 1994). 
Re-classification of P2 receptors 
A new P2 purinoceptor subclassification scheme rather different from the above- 
described current classification has recently been proposed by Abbracchio and 
Burnstock (Abbracchio & Burnstock 1994). In this new scheme, P2 purinoceptors are 
divided into three groups: - P2X1 - P2X4 for ligand-gated ion channels (Table 1-2), 
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nonselective pore-forming receptors. 
1.2 Signal Transduction 
The main signal transduction pathways involved in the actions of extracellular 
nucleotides are briefly summarized in Figure 1-1. 
P2X purinoceptor - ligand-gated ion channels 
Activation of P2X purinoceptors leads to the opening of ion channels. Most reported 
ATP-activated ion channels, including the two cloned P2x receptors, have been shown 
to be non-selective cation (K+, Na+, Cat+) ion channels, but in developing chick 
skeletal muscle a single class of ATP-activated ion channels was found to be permeable 
to both cations (K+, Na+, Cat+) and anions (Cl-, NO3-) (Thomas & Hume 1990). 
p2Y/2U/2T/2D purinoceptors -G protein-coupled membrane receptors 
P2Y' Pzu, P2T and P2D purinoceptors form a distinct large receptor family and are all 
coupled to G-proteins (Webb et al. 1993, Lustig et al. 1993, Murgo et al. 1994, 
Gasmi et al. 1994, Castro et al. 1994). P2Y, P2U and P2D in most cases are 
predominantly linked to PLC, resulting in an increase in phospholipid turnover, 
intracellular Cat+mobilization and formation of diacylglycerol (DAG) (Berridge 1993). 
In addition to the inositol phosphate (EP) and Ca2+ signalling, other G protein-linked 
signal pathways are also involved in signal transduction from P2 receptors, which may 
be secondary to activation of the PLC(IP/Ca2+/DAG system. For example, increased 
intracellular Caz+ can exert its effects on adenylate cyclase in a inhibitory (e. g.: in 
pituitary cells and cardiac cells) or stimulatory fashion via the complex of Caz+- 
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& Brooker 1993). In neuroblastoma x glioma hybrid cells (NG108-15) (Snider et al. 
1984), C6-2B glioma cells (Debernardi et al. 1991, Munshi et al. 1994, Debernardi 
et al. 1993a) and cardiac tissue (Cooper & Brooker 1993), the increased cytosolic 
Ca2+ functions as a negative allosteric effector to reduce adenylate cyclase activity is 
thought to be responsible for the inhibition of agonist-stimulated accumulation of cAMP 
(Steer & Levitzki 1975, Debernardi et al. 1993b). The P2 receptor-mediated reduction 
in agonist-stimulated cAMP accumulation might also occur at the level of 
phosphodiesterase, some of which can be activated by Cat+-calmodulin (Erneux et al. 
1985, Tanner et al. 1986). However, some evidence suggests that P2-purinoceptors 
directly couple to adenylyl cyclase via PTX-sensitive G-proteins, thus inhibiting the 
generation of cAMP in ventricular myocytes (Yamada et al. 1992), rat hepatocytes 
(Okajima et al. 1987), FRTL-5 thyroid cells (Okajima et al. 1989, Sato et al. 1992) 
and C6 glioma cells (Boyer et al. 1993, Lin & Chuang 1994). In renal LLC-PK1 cells, 
inhibition of AVP-stimulated cAMP accumulation by P2Y receptors was PTX- 
insensitive but partially prevented by GDPßS (Anderson et al. 1991), and in rat sertoli 
cells PTX blocked the inhibition of follicle stimulating hormone (FSH) -stimulated 
cAMP accumulation by P2U receptors to a different degree dependent on the agonists 
used (Filippini et al. 1994). 
In addition to their inhibitory effect on agonist-stimulated CAMP accumulation, P2 
receptors might also directly or indirectly increase CAMP. Such action has been 
observed in bovine vascular (aortic) smooth muscle cells (Tada et al. 1992), Swiss 
3T3 and 3T6 mouse fibroblasts, porcine aortic smooth muscle cells and A431 human 
epidermoid carcinoma cells (Huang et al. 1991, Wang et al. 1992, Wang et al. 1994) 
and PTX-treated FRTL -5 thyroid cells (Sato et al. 1992). 
The diverse class of enzymes known as phospholipase A2 (PLA2) are activated by P2 
receptors and thought to play an important role in phospholipid metabolism and signal 
transduction. Many of them are Cat+-dependent enzymes but several Cat+-independent 
PLA2 have also been reported (Dennis 1994). It was generally believed that activation 
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of PLA2 and arachidonic acid release by P2 receptors was downstream of 
PLC/IP/Ca2+. However, in 3T3,3T6, and A431 cells (Huang et al. 1991) and in 
porcine aortic smooth muscle cells (Wang et al. 1992) PTX blocked P2 receptor- 
activated arachidonic acid release and prostaglandin synthesis, suggesting that P2 
receptors may directly couple to PLA2 via PTX-sensitive G proteins. This suggestion 
was supported by recent genetic findings that a mutation of G subunit with single 
amino acid change from Glycine(203) to Threonine inhibited thrombin and ATP 
receptor stimulation of arachidonic acid release independent of adenylate cyclase 
inhibition and Ca2+ mobilization (Winitz eta! 1994). 
In some cell types, phospholipase D (PLD) and cGMP are also involved in P2 receptor 
signal transduction, and activation of PLD and cGMP generating system appear to be 
dependent on the PLC/IP/Ca2+ system (Martin & Michaelis 1989, Purkiss et al. 1993, 
Gustavsson et al. 1993, Snider et al. 1984). 
The signalling mechanism for P2T receptors is slightly different from those for 
P2Y/PZU/P2D. Either inhibition of the adenylate cyclase/cAMP system or stimulation of 
the PLC/IP/Ca2+ system or both are employed as the main signal transduction pathways 
for PZ. I. receptors in platelet (Cooper & Rodbell 1979), K562 leukaemia cells (Murgo & 
Sistare 1992), megakaryocytic Dami cells (a human megakaryocytic leukaemia cell line) 
(Murgo et al. 1994) and UMR-106 osteoblasts (Sistare et al. 1994). Recently an 
atypical P2T receptor was found in brain capillary endothelial cells, where ADP induced 
the mobilization of a thapsigargin-sensitive intracellular Ca2+ pool in a manner 
independent of the formation of inositol phosphates (Frelin et al. 1993, Vigne et al. 
1994). In addition, there is some evidence to suggest that ADP activates ligand-gated 
ion channels in human platelets (Mahautsmith et al. 1990). 
P2Z purinoceptor - ion channels and/or membrane pores 
The signal transduction mechanism is poorly understood. Activation of the P2 
purinoceptor increases plasma membrane permeability by opening ion channels (for 
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cation influx such as Na+, K+ and Caz+) and/or by formation of membrane pores 
(permeable to molecules with Mr up to about 900 such as N-methyl-D-glucamine 
(NMG+), ethidium+ and fura-2) (Nuttle & Dubyak 1994, Chen et al. 1994a). 
1.3 Molecular Biology of P2 Purinoceptors 
The molecular cloning of two ATP-gated ion channel receptors and two G protein- 
linked ATP receptors are exciting and very recent developments in the field. 
ATP-gated ion channels 
Two cDNAs encoding for putative P2X receptors were independently isolated from vas 
deferens and PC 12 cells, and represent two distinct subtypes of intrinsic non-selective 
cation ion channels (Valera et al. 1994, Brake et al. 1994). Surprisingly, the 
pharmacological agonist4 profiles for these two clones do not fit well into the widely 
used Pyt purinoceptor agonist potency criteria (i. e. a, p-methylene ATP > ß, -tmethylene 
ATP > ATP, 2-methylthioATP) (Burnstock & Kennedy 1985). The putative P2XR1 has 
472 amino acids with a predicted mass of 52.6 KDa (Brake et al. 1994), consistent 
with the findings of a 50 to 53 KDa membrane protein labelled with [32P]BzATP (3'- 
0-4-benzoylbenzoyl ATP) in PC12 cells (Majid et at. 1992, Rhoads et al. 1993), 
suggesting that the P2X receptor, at least in PC 12 cells, is not glycosylated. The 
cloned, ionotropic ATP receptor from PC12 cells (P2xR1) (Brake et al. 1994), when 
expressed in Xenopus oocytes, showed the following rank-order of agonist potency in 
production of inward currents: ATP = 2-methylthioATP »> a, ß-methylene ATP and 
p, y-methylene ATP. This agonist profile resembles those previously found for 
ionotropic ATP receptors in PC12 cells (Nakazawa et al. 1990a, Majid et al. 1992, 
Rhoads et al. 1993), rat parasympathetic cardiac ganglia (Fieber & Adams 1991), in 
rat sympathetic neurons (Cloues et al. 1993), neurons of guinea pig submucous plexus 
(Barajas-Lopez et al. 1994), guinea-pig intracardiac neurons (Allen & Burnstock 
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1990), rat nucleus solitarii neurons (Ueno et al. 1992a) and rat microglial cells 
(NÖrenberg et al. 1994, Langosch et al. 1994) 
Simultaneously, another ionotropic ATP receptor was cloned from rat vas deferens by 
Valera, et al (Valera et al. 1994). This cDNA, when transiently expressed in human 
embryonic kidney HEK293 cells, exhibited the following agonist potency in evoking 
inward currents: 2-methylthioATP z ATP > a, ß-methylene ATP > ADP, closely 
resembling those observed in rabbit ear artery smooth muscle (Benham et al. 1987, 
Benham & Tsien 1987) and rat locus coeruleus neurons (Tschöpl et al. 1992, Shen & 
North 1993). This putative P2x receptor has 399 amino acids with a predicted mass of 
45 KDa, apparently smaller than the reported Pyt receptor of 62 KDa solubilized from 
rat vas deferens (Bo et al. 1992). These two molecules might be identical - the higher 
mass of 62 KDa due to glycosylation, or representative of two different proteins since 
there are two [3H] a, ß-methylene ATP binding sites detected in rat vas deferens (Bo et 
al. 1992). 
Both cloned ATP-gated ionotropic receptors share around 40% amino acid sequence 
identity (Figure 1-2). Their overall structures are very similar: - containing two 
hydrophobic putative transmembrane domains (about 20 and 28 amino acids) linked by 
a large extracellular hydrophilic cysteine-rich domain (about 280 amino acids) to both 
N- and C-terminals, which are intracellular. Both receptors bear no apparent sequence 
identity to any other receptor proteins and it appears that ATP-gated intrinsic ion 
channels form their own distinct family. Strikingly, both receptors have approximately 
45% sequence identity with RP-2, a partial cDNA clone isolated from rat apoptotic 
thymocytes (Owens et al. 1991). The implication for such high sequence similarity is 
unknown at present. 
The tissue distribution for these two putative P2x receptors are very wide. Transcripts 
have been detected in brain, spinal cord, the superior ganglion, intestine, vas deferens, 
bladder, adrenal gland, pituitary and testis but not in heart, kidney, liver, ovary, lung, 
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spleen and skeletal muscle by the PC 12 cDNA in Northern blots or in situ 
hybridization (Brake et al. 1994). Transcripts corresponding to the rat vas deferens 
cDNA were detected in bladder, lung, spleen, spinal cord, coeliac ganglia, PC 12, retina 
and thymus (Valera et al. 1994). The distribution obviously overlaps and this may 
reflect the presence of multiple subtypes of P2X receptor in a given cell type or tissue, 
or may result from the high nucleic acid sequence similarity (> 50%) between these two 
clones. 
G protein-coupled purinoceptors 
A cDNA (P2R) isolated from mouse NG108-15 neuroblastoma x rat C6 glioma hybrid 
cells (Lustig et al. 1993) has been characterized to encode a functional Peu receptor 
with the following agonist potency in activation of PLC when expressed in Xenopus 
laevis oocytes (Lustig et al. 1993) or K-562 human leukaemia cell line (Erb et al. 
1993): ATP = UTP » ADP, 2-methylthioATP and ß, r-methylene ATP. The cDNA 
gives rise to a 373 residue protein with a predicted mass of 42 KDa. Glycosylated, this 
cloned Peu receptor protein expressed in K-562 human leukaemia cells occurs as a 53 
KD membrane protein as determined by photoaffinity labelling with [32P]BzATP (Erb 
et al. 1993). Interestingly, [32P]BzATP labelling was inhibited by ATP but not UTP, 
suggesting that each nucleotides may have a distinct binding site on the receptor (Erb et 
al. 1993). A putative human Peu receptor cDNA, isolated from an airway epithelial cell 
line (CF/T43) and a colonic epithelial cell line (HT-29) (Parr et al. 1994), has an 89% 
DNA sequence homology and functional similarities to the mouse neuroblastoma P2U 
receptor. 
A putative receptor cDNA (P2Y1) was obtained from the embryonic chick brain and 
showed a agonist potency order characteristic of P2y receptors: - 2-methylthioATP z 
ATP > ADP »> UTP, a, ß-methylene ATP and ß, y methylene ATP in the production 
of slow inward currents (Webb et al. 1993). It has 362 amino acids with a predicted 
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Table 1-4. Amino acid homology comparison of the cloned P2Y1 and P2U purinoceptors 
with other known G-protein coupled receptors. 
Receptor Species 
% Identity 
with P2y1 (chick) 
% Identity 
with P2U (murine) 
RDC1 canine 27 
angiotensin II type I human / (bovine) 27 (22) 
Thrombin human 25 25 
Platelet-activating factor guinea-pig 25 25 
C5a anaphylatoxin human 23 
Neuromedin K rat 23 
Interleukin 8 human / (rabbit) 22 (23) 
Bradykinin B2 rat 22 
GPRN1 * human 21 
Neurotensin rat 21 
Endothelin B human 21 
Gastrin-releasing peptide murine 21 
Adenosine Al canine 21 
Substance P human 20 
Neurokinin 2 human 20 
Adenosine A2 canine 18 
cAMP slime mold 17 
Adenosine unknown < 12 
cAMP unknown < 12 
*: a putative vasoactive interstinal peptide receptor. 
Figures in brackets correspond to the species in brackets. Data adapted from Lustig, 
1993 and Webb, 1993. 
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These cloned receptors (P2U and P2Y) showed structural features characteristic of G 
protein-coupled receptors including seven hydrophobic transmembrane domains (a- 
helices), consensus sequences for N-linked glycosylation near the N-terminal and two 
conserved cysteine residues in the first two extracellular loops (Figure 1-3). They are 
among the smallest proteins (362 amino acids for the P2y1 and 373 for the P2R) in the 
superfamily of G protein-coupled receptors and share approximately 40% amino acid 
sequence identity. The homology of both receptors to other members of the G protein- 
coupled receptor family is low (Table 1-4). Northern blotting shows a wide tissue 
distribution for these cloned receptors. Transcripts for P2Y1 were detected in the brain, 
spinal cord, gastro-intestinal tract, spleen and skeletal muscle, but not in heart, liver, 
stomach, lung and kidney (Webb et al. 1993), and the P2R was seen in the spleen, 
testis, kidney, liver, lung, heart and brain (Lustig et al. 1993). 
1.4 ATP receptors in the CNS 
Since Burnstock's first proposal that purinergic nerves, which release ATP as their 
primary neurotransmitter (Su et al. 1971), might mediate nonadrenergic and 
noncholinergic relaxation of gastrointestinal smooth muscle (Burnstock et al. 1970), a 
large body of evidence has accumulated to unambiguously demonstrate that ATP, 
released upon stimulation and acting on ATP receptors, is a neurotransmitter in the 
autonomic nervous system and peripheral sensory nerves (Burnstock 1972, Burnstock 
1976, von Kugelgen & Starke 1985, Evans et al. 1992, Trezise et al. 1993, Krishtal 
et al. 1983, Krishtal et al. 1988, Bean 1990, Bean et al. 1990). 
As in peripheral tissues, multiple ATP receptors (mainly P2X, P2Y9 P2U and P2D) are 
expressed in the CNS (Valera et al. 1994, Brake et al. 1994, Lustig et al. 1993, 
Webb et al. 1993, Hilderman et al. 1991). P2X receptors in the CNS are largely 
confined to neurons (Salt & Hill 1983, Jahr & Jessell 1983, Tschäpl et al. 1992, 
Harms et al. 1992, Ueno et al. 1992b, Edwards et al. 1992, Bean 1992, Shen & 
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North 1993) but also present in microglial cells (Nörenberg et al. 1994, Langosch et 
al. 1994). Binding experiments show that a widespread distribution of [3H]a, ß- 
methylene ATP binding sites (as an indication for P2 receptors) in rat brain and spinal 
cord, and many structures in the CNS are densely labelled including thalamus, 
amygdaloid, substantia nigra, cerebral cortex, hypothalamus, caudate putamen, 
geniculate nuclei, medial habenula and the intermediate zone of grey matter in the spinal 
cord (Bo & Burnstock 1994, Michel & Humphrey 1993)., Though the P2y1 receptor 
was cloned from brain tissue and its transcripts were highly expressed in brain tissue 
(Webb et al. 1993), the available data seems to suggest that the G protein-linked P2 
receptors in the CNS are largely located in non-neural cells (Kastritsis et al. 1992, 
Bruner & Murphy 1993, Boyer et al. 1993, Munshi et al. 1994, Lin & Chuang 
1994). However, a presynaptic P2Y receptor (von Kugelgen et al. 1994) has been 
defined and P2U receptor has also been found in N1E-115 neuroblastoma cell line 
(Iredale et al. 1992a), hinting that nucleotides may also be involved in slow synaptic 
transmission and metabotropic actions via G proteins. 
Neurons 
ATP-evoked excitatory responses have been observed in many types of central 
neurons: - these include cerebral cortical neurons (Phillis et at 1975, Phillis et at 
1979), caudal trigeminal nucleus (Salt & Hill 1983), nucleus tractus solitarii neurons 
(Ueno et at 1992b), rostral ventrolateral reticular nucleus of the medulla oblongata 
(into which the microinjection of ATP produced a powerful pressor response (Sun et 
at 1992)), caudal medulla neurons (Day et at 1993), locus coeruleus neurons 
(Harms et al. 1992, Tschäpl et al. 1992, Shen & North 1993), medial habenula 
neurons (Edwards et at 1992), vestibular and auditory cells (Shigemoto & Ohmori 
1990, Nakagawa et al. 1990, Dulon et al. 1991, . Housley et at 1992, Aubert et al. 
1994, Nilles et at 1994), hippocampal neurons (Wieraszko & Seyfried 1989, Inoue 
et at 1992, Mironov 1994), thalamus neurons (Mironov 1994), hypothalamic neurons 
(Chen et al. 1994a), and neurons in the dorsal horn of spinal cord (Jahr & Jessell 
1983, Fyffe & Perl 1984, Salter & Henry 1985, Salter & Hicks 1994). 
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In addition to acting on postsynaptic P2 purinoceptors, ATP, co-released with 
noradrenaline or acetylcholine, also plays a feedback role in modulation of transmitter 
release via presynaptic P2 purinoceptors in the autonomic nervous system. The 
inhibition is thought to be the main form of modulation in sympathetic neuro-effector 
transmission and has been seen in the mouse and rat isolated vas deferens (von 
Kugelgen et al. 1989, Kurz et al. 1993, von Kugelgen et al. 1994, Todorov et al. 
1994) and chick sympathetic neurons in culture (Allgaier et al. 1994). The facilitation 
on noradrenergic and/or cholinergic transmission, however, has also been reported in 
the rabbit ear artery (Miyahara & Suzuki 1987), guinea pig ileum (Sperlagh & Vizi 
1991), saphenous artery (Todorov et al. 1994) and rat sympathetic neurons (Boehm 
1994). One can speculate that such ATP-mediated presynaptic modulation may be 
common to the CNS, particularly in noradrenergic and cholinergic pathways. This is 
supported by the finding that in rat cortical noradrenergic axons, a separate P2- 
purinoceptor, in addition to the known adenosine Al-receptor, was identified (P2y-like 
subtype) and functioned as if it was in the peripheral sympathetic nervous system (von 
Kugelgen et al. 1994). 
Glial cells 
Glial cells, as a constitutional and functional part of the central nervous system, are 
critical for maintenance of synaptic transmission and play an important role in the 
modulation of synaptic efficacy (Keyser & Pellmar 1994). Astrocyte (Kastritsis et al. 
1992), oligodendrocytes (Salter & Hicks 1994) and microglial cells (Walz et al. 1994) 
are all direct targets for extracellular nucleotides via various P2 purinoceptors, which 
mediate a variety of biological processes in glial cells. These include activation of the 
IP/Ca2+ system (Kastritsis et al. 1992, Salter & Hicks 1994, Lin & Chuang 1993, Lin 
& Chuang 1994), increase in prostaglandin synthesis (Gebicke-Haerter et al. 1988), 
thromboxane release (Bruner & Murphy 1993), inhibition of agonist-stimulated cAMP 
accumulation (Debernardi et al. 1993a, Boyer et al. 1993), changes in morphology 
(Neary & Norenberg 1992), activation of ion channels (Walz et al. 1993, Walz et al. 
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1994, Niirenberg et al. 1994, Langosch et al. 1994) and increase in glial fibrillary 
acidic protein and DNA synthesis (Neary et al. 1994, Neary et al. 1994, Abbracchio 
et al. 1994). In addition, a 53 kDa protein was identified on astrocyte membranes by 
immunoblotting with an antibody raised against a putative rat fibroblast P2U receptor 
(Bruner & Murphy 1993). These data clearly suggest an important role for extracellular 
nucleotides in the neuron-glia interaction and in the regulation of glial cell functions. 
1.5 Summary 
A wealth of data - particularly the recent recording of synaptic potentials between 
neurons, and the cloning of four P2 purinoceptors - have unambiguously demonstrated 
that ATP and other nucleotides are ubiquitous extracellular mediators involved in many 
biological processes. The superfamily of P2 purinoceptors can be divided into two main 
groups: - ligand-gated ion channels (Pu) and G protein-coupled receptors (P2Y, P2U, 
P2T and P2D), with P2Z receptors, forming a separate category of apparent ion 
channels/membrane pores. Multiple P2 receptors are expressed in the neurons as well 
as in a variety of non-neuronal cells. After long controversy, the extracellular nucleotide 
field is now established, and is rapidly becoming one of the most fascinating areas of 
transmitter research. The physiological and pathological significance of P2 receptors 
still awaits full-scale exploration. 
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Chapter 2. GENERAL METHODS 
A list of materials used in the following methods and their suppliers is provided at the 
end of this chapter unless otherwise specified. 
2.1 Cell Culture 
2.1.1 Rat Hypothalamic neurons 
Foetal rat hypothalami were harvested and dispersed essentially as described(Hu et al. 
1992). A Sprague-Dawley rat on days 18-20 of pregnancy (the day of mating referred 
to as day 1) was decapitated and the abdomen was cleaned with 70% ethanol and cut 
open. The uterus (usually containing 11 - 15 fetuses) was removed and placed into 
dissection solution (Table 2-1) in a sterile plastic petri dish. Fetuses were then removed 
from the uterus and decapitated and fetal heads placed onto a piece of 3M filter paper 
soaked in dissection solution in a petri dish. One mid cut was made through the dorsal 
skull and the whole fetal brain gently eased out and inverted so that the hypothalamus 
was visible. The hypothalamus, bordered by the hypothalamic sulci laterally, the 
mammillary bodies caudally and the optic chiasm rostrally were taken using fine 
watchmaker forceps and placed into ice-cold collection buffer (Table 2-1). All tissue 
dissection and cell dispersion instruments were autoclaved before use. 
Washed once in fresh collection buffer, the hypothalami were cut into small pieces with 
a sterile scalpel and digested by dispase II in 5 ml of enzyme solution (Table 2-1) in a 
shaking waterbath at 37°C for 30 min. After digestion the tissue was gently passed 
through 20-gauge needles twice to facilitate disruption of tissue and the supernatant 
collected into 10 ml of collection buffer. The remaining hypothalamic fragments were 
digested once more as described above. The collected supernatant was sieved through a 
mesh with openings of 0.23 mm in diameter and then centrifuged at 1000 rpm for 8 
min. The cell pellet was resuspended in 2 ml of collection buffer, and this cell 
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suspension was transferred into 20 ml of debris removal buffer (Table 2-1) and 
centrifuged again. 
The final cell pellet was resuspended in culture medium (Table 2-1), plated at a density 
of 2x 105/cm2 on 22 mm diameter, poly-L-lysine coated glass coverslips, and 
maintained at 37°C in a water-saturated atmosphere of 5% CO2 in air. The culture 
medium remained unchanged for the first 4 days of culture, after which the serum 
content of the medium was reduced to 2.5% and half the medium was changed every 3 
days. In order to suppress the growth of non-neuronal cells, 10 µM cytosine 
arabinoside was added to the medium for 30 hours between days 4 and 5. After 5 days 
in culture, hypothalamic cells formed a neuronal network and after 7 days, elaborate 
cell connections with long neuntes were observed. 
2.1.2 Rat Pituitary Cells 
To obtain rat pituitary glands, rats were decapitated, head and neck fur trimmed back 
with scissors and the cranium cut open widely with bone forceps. A steel spatula was 
inserted under the frontal lobes to rotate the brain posteriorly out of the cranium leaving 
the pituitary gland exposed under the diaphragm sella. A sterile 19-gauge needle was 
used to split the diaphragm and score the medial sides of the cavernous sinuses on 
either side so that the pituitary was impaled, lifted from the pituitary fossa and placed in 
5 ml of ice-cold HBSS containing 0.1% BSA, 20 mM HEPES, 100 unit/ml penicillin 
and 100 µg/ml streptomycin. 
pituitary glands were washed once in HBSS, transferred into a sterile petri dish with a 
few drop of HBSS and cut into small pieces with a sterile scalpel. The minced pituitary 
tissue was then transferred to a sterile Bijou bottle, washed in 4 ml of HBSS to remove 
blood and digested in 3 ml of HBSS containing trypsin (0.125% w/v), DNase I (0.5 
mg/ml), BSA (0.1%) and HEPES (20 mM) at 37°C in a shaking waterbath. After 20 
min of digestion the tissue fragments were passed through a 10 ml-pipette several times 
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Table 2-1. Solutions used in culture of rat hypothalamic neurons * 
dissection solution saline 
50 unit/ml penicillin 
50 µg/ml streptomycin 
collection buffer Ca/Mg-free Hanks' balanced salt solution (HBSS) 
0.1 % w/v bovine serum albumin (BSA) 
20 mM HEPES 
5.6 mm o-glucose 
50 unit/ml penicillin 
50 µg/ml streptomycin 
enzyme solution 2.4 units/ml dispase II in phosphate buffered saline 
0.5 mg/ml DNase I 
debris removal buffer collection buffer 
4% BSA 
culture medium Dulbecco's modified Eagle's medium/nutrient mix F12 
10 % fetal calf serum (FCS) 
100 unidml penicillin 
100 µg/ml streptomycin 
0.25 µg/ml fungizone 
*: Items are ordered as appeared in the text. 
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and the supernatant was harvested into 20 ml of culture medium (Dulbecco's modified 
Eagle's medium (DMEM) supplemented with 5% FCS, 5% horse serum, 100 unit/ml 
penicillin, 100 pg/ml streptomycin and 2 mM glutamine). The remaining tissue 
fragments were subject to further rounds of enzymatic digestion as described above. 
Usually, it took 4-5 runs to complete dispersion. Dispersed cells were plated out on 
22 mm diameter glass coverslips in culture medium at 37°C in a water-saturated 
atmosphere of 5% CO2 in air. 
2.1.3 Gonadotrope-derived Cell Line (aT3-1 Cells) 
aT3-1 cells were kindly provided by Dr P. Mellon (Department of Reproductive 
Medicine, University of California, San Diego, CA, USA), and maintained in DMEM 
supplemented with 5% FCS, 5% horse serum, 100 unit/ml penicillin, 100 tg/ml 
streptomycin and 2 mM glutamine at 37°C in a water-saturated atmosphere of 5% CO2 
in air and passaged at 7-day intervals by trypsinization. 
2.2 Real-time Intracellular Calcium Ion Imaging at the Single Cell Level 
The introduction of fluorescent Ca2+ indicators such as Fura-2 over the last decade has 
revolutionized the measurement of intracellular Cat+. In this study Fura-2 was used to 
examine intracellular Ca2+ signalling at the single cell level in many cell types in a 
computerized real-time Ca2+ imaging system (Figure 2-1). 
Fura-2, the most popular fluorescent Ca2+ indicator available today, is a dual excitation 
dye that will fluoresce at two different excitation wavelengths when bound to calcium 
ions (Figure 2-2). The peak fluorescence occurs with an excitation wavelength of 
approximately 380 nm and 340 nm for the low and high Ca2+ concentrations, 
respectively. 340 and 380 nm excitation wavelength are used to generate two different 
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Figure 2-2. Spectral responses of Fura-2. 
according to the Grynkiewicz equation (Grynkiewicz et al. 1985): 
[Ca2+1 = Kdß [(R - Rmm) / (Rmax - R)1 
Where Kd = 225 nM 
ß= Imax380 / In80 (I =fluorescence intensity at 510 nm) 
R= the measured ratio of I340 11380 
RMM = Imm340 / 1Imax380 
and Rmax = Ifl 340 / Imin380. 
300 340 380 
Excitation wavelength (nm) 
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For Ca2+ imaging experiments, cells were cultured on sterile thin glass coverslips (22 
mm in diameter, No 1 1/2). Before Ca2+ imaging, they were washed with Ca2+ buffer 
containing 130 mM NaCl, 5 mM KCI, 1.8 mM CaC12,1.2 mM MgSO4,0.5 mM 
NaH2PO4,5 mM NaHCO3,10 mM glucose, 10 mM HEPES and 0.1% BSA and 
loaded with Fura-2 AM in the above buffer for about 30 - 75 min (dependent on cell 
types) at 37°C. Fura-2 AM is the ester form of Fura-2 and can diffuse across the cell 
membrane into the cytosol where it is rapidly de-esterified by non-specific cytoplasmic 
esterases resulting in the membrane-impermeable free acid form. After loading, the cell 
was thoroughly washed with the Ca2+ buffer to remove any excess Fura-2 AM and 
subject to imaging data collection within 30 min. 
Real time Ca2+ imaging was performed as previously described (Mason et al. 1990, 
Kato et al. 1992) at 35°C using % 340 nm and ? 380 nm excitation alternating at 
approximately 0.6Hz (i. e. approximately 3.4 seconds between ratioed images), 
although up to 25Hz was used to estimate response times. The emitted fluorescent at A. 
510 nm was passed to an image-intensifying charge-coupled device (ICCD) camera. 
The resulting fluorescence images at each excitation wavelength were averaged 8- 16 
times in real time, digitized to yield 256 grey levels and captured as 256 x 256 pixel 
images using the MagiCal system and 'TARDIS' software package supplied by Applied 
Imaging International Ltd.. On a pixel-by-pixel basis, the ratio of emitted fluorescence 
(X340nm/. 380nm) was calculated for each frame after background subtraction, 
automatically compared with a calibration curve and converted to intracellular Ca 2+ 
concentration ([Ca2+]; ). 
The Ca2+ imaging system was calibrated by imaging the cells of interest under 
artificially raised or reduced intracellular Ca2+ concentrations. After loaded with Fura-2 
AM, cells were imaged in the elevated extracellular Ca2+ concentration of 10 mM and 
the saturated intracellular Ca2+ concentration was achieved by addition of ionomycin (2 
µM), which causes a rapid and sustained rise in intracellular Ca 2+ concentration. The 
same cells were then washed and bathed in the Ca2+-free medium containing 5- 20 mM 
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EGTA, which leads to Ca2+ efflux and almost elimination of intracellular free Ca2+ 
within approximately 1 hour. By this mean, the above-described parameters of Rte, 
R and ß were obtained and an individual calibration curve was produced for each 
type of cell of interest. An example of calibration curve for cultured hypothalamic 
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Figure 2-3. Ca2+ imaging calibration curve for cultured hypothalamic neurons 
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2.3 Immunocytochemistry 
Immunocytochemistry was performed using the avidin: biotin complex method with 
peroxidase substrate (ABC-P) essentially as described (Mikkelsen & O'Hare 1991). 
Experiments were carried out at room temperature unless specified. Cells on glass 
coverslips were washed in HBSS for 2x5 min and fixed in 4% paraformaldehyde in 
phosphate buffered saline (PBS) for 15 min. After rinsed in 2 ml of KPBS buffer 
(Table 2-2) for 3x 10 min, cells were incubated sequentially in 1 ml of 1% H202 in 
methanol for 15 min to block endogenous peroxidase and in 0.5 ml of blocking buffer 
for 20 min. Cells were then incubated with the primary antibody at appropriate dilutions 
in antibody buffer (Table 2-2) at 4°C for 24 hours. Cells were afterwards rinsed in 
washing buffer for 3x 10 min and incubated with appropriate biotinylated secondary 
antibody (1: 400 dilution) in antibody buffer for 1 hour. Cells were rinsed again in 
washing buffer for 3x 10 min and incubated in Dako avidin: biotin: peroxidase mixture 
for 1 hour. The avidin: biotin: peroxidase mixture was then removed by sequentially 
rinsing in washing buffer, KPBS buffer and 0.05 M Tris-Cl buffer (pH 7.6) each for 
10 min. Immunostaining was developed by incubating cells in chromagen solution for 
1 min, followed by washing cells in distilled H2O for 2x 10 min. Finally, cells on 
coverslip were mounted onto glass slides with DPX mountant. 
For detection of neuron-specific markers microtubule-associated protein 1 (MAP! ) in 
hypothalamic culture, monoclonal anti-rat MAP! (1: 500 dilution), normal rabbit serum 
and rabbit anti-mouse IgG were used as the primary antibody, normal serum and 
secondary antibody, respectively, while polyclonal rabbit anti-bovine NSE (1: 400 
dilution), normal swine serum and swine anti-rabbit IgG used correspondingly for 






Table 2-2. Solutions used in ABC-P immunocytochemistry * 
KPBS buffer PBS 
2.6 mM KC1 
blocking buffer KPBS 
5 % normal serum 
1 % BSA 
0.3 % Triton-X- 100 
antibody buffer KPBS 
1 % BSA 
0.3 % Triton-X-100 
washing buffer KPBS 
0.25 % BSA 
0.1 % Triton-X-100 
chromagen solution 0.05 M Tris-Cl buffer (pH 7.6) 
0.04 % diaminobenzidine tetrahydrochloride 
0.001 % H202 
*: Items are ordered as appeared in the text. 
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2.4 Superfusion of Pituitary Cells 
Rat pituitary glands were acquired and enzymatically dispersed using a similar 
procedure to that described above for pituitary cell culture but the enzyme solution for 
tissue digestion was comprised of 1 mg/ml collagenase, 0.5 mg/ml hyaluronidase, 25 
µg/ml DNase, 0.3% BSA in medium M199 (McArdle & Poch 1992). Aliquots of cell 
suspension containing approximately 3-4x 106 cells in culture medium M 199 
supplemented with 5% FCS, 5% horse serum, 0.3% BSA, 2 mM glutamine, 20 mM 
HEPES and 50 µg/ml gentamycin were plated out on a 12-well culture plate containing 
15 mg Cytodex I beads, which had been pre-swollen in phosphate-buffered saline and 
autoclaved. Cells were maintained at 37°C in a humidified air atmosphere. 
Superfusion experiments were performed as previously described (McArdle & Poch 
1992). After 2 days in culture, cells and beads were transferred to superfusion columns 
(5 x 25 mm Bio-Rad Econocolumns) and superfused with medium M199 containing 
0.3% BSA, 1.8 mM Ca2+, 2 mM glutamine and 20 mM HEPES at 37°C at the rate of 
0.65 ml/min. A schematic diagram of the superfusion system used is shown in Figure 
2-4. A 90 min-superfusion was carried out to wash cells before the start of superfusate 
collection. Superfusate fractions were collected for periods of 1- 9 min and stored at - 
20°C while awaiting determination of pituitary hormone by radioimmunoassay (RIA). 
The experiments were performed at 37°C. The dead space in the superfusion system 
was approximately 0.4 ml, which resulted in a time lag of approximately 40 sec 
between changes of medium and collection of superfusate containing the new medium. 
This time lag was not corrected for the data presented in this thesis. 
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stimulus reservoir 








superfusion column containing cells 
Figure 2-4. Schematic diagram of the superfusion system. 
2.5 Luteinizing Hormone (LH) Radioimmunoassay 
LH RIA was carried out as described (McArdle & Poch 1992) and is shown in Table 2- 
3.200 p1 of superfusate collected in the superfusion experiments of rat pituitary cells 
were used per tube and the assay performed in duplicate. Rat LH standard (NIDDK- 
rLH-RP3) was diluted 1: 1 sequentially in 200 µl of superfusion medium (i. e. medium 
M199 containing 0.3% BSA, 2 mM glutamine and 20 mM HEPES) to construct 
standard curve with amounts of LH ranging from 10 pg to 5000 pg per tube. Rabbit 
anti-rat LH antibody (NIDDK-anti-rLH-S 10) in 100 µ1 of superfusion medium (final 
titre of 1: 18000) was added to each tube except nonspecific binding and total count 
tubes. After addition of radiolabelled LH ([125I]LH: - 20000 cpm in 100 Al of 
superfusion medium) to each tube, samples were mixed, covered with parafilm and 
incubated at room temperature for 24 hours. 500 p1 of precipitant containing 20% PBS, 
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Table 2-3. Luteinizing hormone radioimmunoassay 
Tube Standard Sample Medium Anti-LH [125I]LH Precipitant 
total 100 
NSB 300 µl "" 500 µl 
Bo 200 100 Al 
10pg 200µl .... .. 
20pg "" .... .. 
40 pg "" "" "" .. 
80pg "" .".. .. 
156 pg "",. 
312pg "" "" .... 
625 pg "".. .... 
1250pg ""  "" 
2500 pg "".,.. .. 
5000 pg "".. .... 
sample 1 200 µ1 "". ".. 
sample 2 ..,,,. 
etc 
7.5% polyethylenglycol-6000,0.1 % Triton-X-100,0.1 % normal rabbit serum and 
1% donkey anti-rabbit serum (added immediately before use) were then added to all 
tubes except total count tubes. Samples were mixed, incubated at room temperature for 
15 min and then separated by centrifugation (3000 rpm, 4°C, 20 min). Supernatant was 
decanted and the pellet counted for 1 min in a gamma counter. 
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Rat LH standard and rabbit anti-rat LH antibody were kindly supplied by the National 
Institute of Diabetes, Digestive and Kidney Diseases, USA and [125I]LH prepared by 
chloramine-T iodination of pure rat LH (NIDDK-rLH-I9) was kindly provided by Miss 
A. Poch (Institute for Hormone and Fertility Research, Hamburg, Germany). 
2.6 Measurement of cAMP Accumulation 
Total (intra- and extracellular) cAMP was extracted and measured essentially as 
described (McArdle et al. 1994). Cells cultured on 24-well plates were washed once 
with a basic salt solution containing in mM: 135 NaCl, 1 KCI, 1.5 CaCl2,0.5 MgC121 
1 KH2PO4,5 KOH, 5.6 glucose, 10 HEPES and 0.1% BSA (henceforth referred to as 
BSS) and preincubated in 0.25 ml of BSS with 0 or 0.25 mM 3-isobutyl-l- 
methylxanthine (IBMX) at 37°C for 10 min. Cells were then incubated at 37°C in 0.25 
ml BSS containing various stimuli as indicated for 10 or 30 min at the presence of 0 or 
0.25 mM IBMX. Incubation was terminated by adding 1 ml of ice-cold ethanol and 
cAMP was extracted by incubating cells at -20°C for 30 min. Cells were then 
centrifuged at 120 xg for 5 min at room temperature and samples of supernatant of 800 
µl were transferred, without disturbing precipitate, into glass tubes. Samples 
evaporated to dryness at 55°C in vortex under vacuum for 40 min and were 
resuspended in 0.5 ml of medium M199 containing 10 mM HEPES (referred to as 
M199-HEPES). Samples containing large amount of cAMP, e. g. in the case of aT3-1 
cells stimulated with forskolin and pituitary adenylate cyclase-activating polypeptide 38 
(PACAP38), were diluted further before acetylation. 1: 50 dilution was given for these 
samples. 
cAMP RIA standards and samples were acetylated by adding ' 25 pI of acetylation 
reagent (1 volume anhydrous acetic acid and 2.5 volumes triethylamine) to 500 µl of 
standards or samples in glass tubes and mixed immediately. cAMP was assayed using a 
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cAMP RIA kit, kindly provided by IBL, Hamburg, Germany and the procedure was 
similar to that described above for LH RIA. Acetylated standards were prepared by 1: 1 
sequential dilution in 100 µl of M199-HEPES to give concentrations of 10 fmol to 
1280 fmol per tube. 100 . tl of acetylated samples were used per tube and the assay 
performed in duplicate. 25000 cpm of [125I]cAMP in 100 µl of M199-HEPES and 200 
µl of cAMP antiserum in cAMP buffer (Table 2-4) with a final titre in RIA of 1: 96000 
were used. Samples were incubated at 4°C for 24 hours, terminated by addition of 1 ml 
of precipitant (supplied by the manufacturer), mixed thoroughly and centrifuged (3000 
rpm, 4°C, 20 min). Supernatant was decanted and pellet counted for 1 min in a gamma 
counter. 
Table 2-4. cAMP buffer 
Solution 1: 0.5 g thimerosal 
5.0 g BSA 
19.8 g Na2SO4 
18.6 g EDTA 
------------------------------------ 
maketo 400mlin H20 
Solution 2: 30 ml acetic acid 
45 g NaCl 
make to 400 ml in H2O 
and to pH 4.5 with 10 M NaOH 
Mix both solutions at 1: 1, adjust pH to 5 and bring volume to 1000 ml 
2.7 Measurement of cGMP Accumulation 
Total (intra- and extracellular) cGMP was extracted and determined by RIA as 
described (McArdle et al. 1993), which was almost the same as one used for the 
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cAMP assay described above but acetylation of samples was not required. A cGMP 
RIA kit, kindly provided by IBL, Hamburg, Germany, was used. 100 µl of samples 
were used per tube and the assay performed in duplicate. 25000 cpm of [125I]cGMP in 
100 gl of M199-HEPES and 200 µl of cGMP antiserum in PBS with a final titre in 
RIA of 1: 160000 were used. 
2.8 Western Immunoblotting of Protein Kinase C (PKC) 
The method used for protein extraction and Western Immunoblotting was kindly 
provided by Dr M. Kratzmeier (Institute for Hormone and Fertility Research, 
Hamburg, Germany). Solutions and buffers were prepared as shown in Table 2-5. 
2.8.1 Preparation of Cytosol and Particulate Protein Fractions 
Cytosolic and particulate fractions were prepared essentially as described by Kiley, et al 
(Kiley et al. 1991). Cells were grown on 75 cm2 culture flasks and, one day prior to 
PKC assay, culture medium was replaced. Concentrated stimuli in a small volume (50 
µl) were directly added to cells in culture and incubated under the same culture 
conditions for 10 min. The cells were then washed with 5 ml of ice-cold buffer A and 
scraped into 1.5 ml of ice-cold buffer B in a2 ml eppendorf tube on ice. Cells were 
homogenized on ice by an ultrasonifying tip (Branson, USA) for -- 7 sec, and the lysate 
was centrifuged at 100,000 g for 40 min at 4°C. The supernatant was collected as the 
crude cytosolic fraction and the crude pellet as particulate fraction. 
The crude cytosolic fraction was purified as follows: protein was precipitated by adding 
trichloroacetic acid (10% final), incubating at room temperature for 15 min and 
subsequently centrifuging at room temperature for 5 min in a bench-top eppendorf 
centrifuge. After discard of supernatant, the precipitate was washed twice with 1 ml of 
ether, vacuum-dried for 30 min to remove residual of ether and dissolved in 200 µl of 
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buffer D by ultrasonification using an ultrasonifying tip for 5x1 sec on ice. The 
sample was centrifuged again and the supernatant (as the cytosol fraction) stored at - 
20°C until use. Protein concentrations of samples were measured by a BioRad kit 
according to the manufacturer's instruction. 
The crude particulate fraction was resolubilized in 200 Al of ice-cold buffer C by 
ultrasonification using an ultrasonifying tip for 5x1 sec on ice, which was then 
centrifuged in an eppendorf centrifuge (14000 rpm, 4°C and 30 min). The supernatant 
(as the particular fraction) was collected and stored at -20°C until use. 
Table 2-5. Solutions used for Western immunoblotting * 








buffer C buffer B 
0.5 % 










Table 2-5. Solutions used for Western immunoblotting * (continued) 
buffer D 50 mM Tris-C1 (pH 6.8) 
12 % glycerol 
1% SDS 
gel solution 3M Tris-Cl (pH 8.4) 
0.3 % SDS 
acrylamide solution 48 % acrylamide 
1.5 % bis acrylamide 
gel sample buffer 50 mM Tris-Cl (pH 6.8) 
4 % SDS 
12 % glycerin 
0.01 % Serva Blue G 
2 % 2-mercaptoethanol 
anode buffer 0.2 M Tris-Cl (pH 8.9) 
0.005 % thimerosol 
cathode buffer 0.1 M Tris-Cl (pH 8.2) 
0.1 M tricine 
0.1 % SDS 
0.005 % thimerosol 
(continued) 
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Table 2-5. Solutions used for Western immunoblotting * (continued) 
blotting buffer 0.1 M Tris-Cl (pH 8.2) 
0.193 M glycine 
0.005 % thimerosol 
TBS (Tris-buffered saline) 20 mM Tris-Cl (pH 7.6) 
0.137 M NaCl 
blocking solution 1 % Boehringer Block Reagent 
0.1 M maleic acid (pH 7.5) 
0.15 M NaCl 
0.005 % thimerosol 
TBST CMS-Tween) TBS 
0.05 % Tween 20 
antibody solution 9 volume TBST 
1 volume blocking solution 
*: Items are ordered as appeared in the text. 
2.8.2 Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis 
(SDS-PAGE) and Western Blotting 
For protein electrophoresis, a 10% polyacrylamide separating gel and 4% stacking gel 
was prepared as shown in Table 2-6 (Schägger & von Jagow 1987). 
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Samples of cytosolic and particulate fractions with equal amount of protein (40 tg per 
lane) in gel sample buffer were heat-treated (95°C, 5 min) and, after cooling, loaded 
into gel. Electrophoresis was run in anode buffer and cathode buffer under 50 V. The 
Amersham RainbowTM coloured protein molecular weight markers of 14.3 - 200 kDa 
were used. The samples were then electrically transferred onto a polyvinylidene 
Table 2-6. SDS-polyacrylamide gel for PKC assay 
1. Separating gel (cast first): 
glycerol 4g 
H2O 11 ml 
gel solution 10 ml 
acrylamide solution 5 ml 
Ammonium persulfate (APS: 10% in stock) 150 µl 
N, N, N', N'-tetramethylethylenediamine (TEMED) 20 µl 
2. Stacking gel (cast over the polymerized separating gel): 
H2O 8.4 ml 
gel solution 3.1 ml 
acrylamide solution 1.0 ml 
APS (10%) 150 
ZEMED 20 µl 
difluoride membrane (Millipore Immobilon P) in blotting buffer under 1 Ampere for 90 
min (Towbin et al. 1979). Following electrotransfer the membrane was stained with 
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0.4% Ponceau S to monitor the transfer efficiency and homogeneity of protein loading 
and, afterwards, destained in TBS buffer at room temperature for 5 min. 
2.8.3 Immunodetecdon of PKC by Enhanced Chendluminescence (ECL) 
PKC was immunochemically detected using an Amersham ECL kit and GibcoBRL 
subtype-specific polyclonal rabbit anti-PKCa, PKCC and PKCE. Experiments were 
performed at room temperature. After nonspecific blocking treatment in blocking 
solution overnight at 4°C, membranes were washed in TBST buffer for 10 min and 
incubated with the primary antibodies at 1: 200,1: 300 and 1: 1000 dilutions for rabbit 
anti-PKCa, PKCC and PKCe, respectively, in antibody solution for 1 hour. 
Membranes were then washed in TBST for 3x 10 min and exposed to peroxidase- 
conjugated goat-anti-rabbit IgG antibody (secondary antibody, 1: 1000 dilution) in 
antibody solution for 1 hour. Membranes were washed again in TBST for 3x 10 min 
and rinsed in H2O. The PKC bands were visualized by immerging the membrane into 
20 ml of the Amersham ECL detection reagent for 1 min and immediately exposing to 
Fuji RX 400 films for 30 seconds. For quantification, the intensity of bands on film 
was analysed using a video imaging-based densitometric system (Jandel Scientific 
Software Ltd, Germany). 
2.9 Molecular Cloning 
2.9.1 mRNA Extraction 
Total RNA from rat pituitary glands was isolated using the RNAzo1TM B solution 
containing guanidinium thiocyanate and phenol. Pituitary glands were homogenized in 
RNAzo1TM B (2 ml per 100 mg tissue) with a few strokes in a glass-Teflon 
homogenizer. 0.1 ml of chloroform were added to each 1 ml of homogenate and mixed 
by shaking vigorously for 15 sec. After staying on ice for 15 min, the sample was 
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centrifuged (12,000 g, 4°C, 15 min) and the upper aqueous phase transferred to a fresh 
tube, to which an equal volume of isopropanol was added. The sample was then 
incubated on ice for 15 min and centrifuged again. The supernatant was discarded and 
the RNA pellet washed with 1 ml of 70% ethanol by vortexing and subsequent 
centrifugation (75,000 g, 4°C, 8 min). The pellet of total RNA dried under vacuum for 
10 min and was dissolved in diethylpyrocarbonate (DEPC)-treated RNase free H20. 
mRNA was then extracted by passing the sample of total RNA through a Stratagene 
Poly(A) Quik mRNA Isolation column of oligo(dT) cellulose and dissolved in H2O and 
stored at -80°C. When working with RNA, a great deal of care was taken to avoid 
contamination by RNase and DEPC-treated solution used where appropriate. 
2.9.2 Reverse Transcription and Polymerase Chain Reaction (RT-PCR) 
mRNA was used as templates to synthesize the single strand cDNA by reverse 
transcriptase and such cDNA then served as templates to amplify a gene of interest by 
PCR technology. The Pharmacia first-strand cDNA synthesis system was used. 100 ng 
of rat pituitary mRNA in 20 µ1 H2O was heated to 65°C for 10 min and then chilled on 
ice. To a fresh RNase free eppendorf tube the followings were added in order and 
mixed: 
Bulk 1st-strand reaction mix 11µl 
Random hexadeoxynucleotides (pd(N)6) primer (0.2 µg/µ1) 1 p1 




Reverse transcription was performed by incubating the above mixture at 37°C for 1 
hour. The bulk 1st-strand reaction mix was supplied by the manufacturer and contained 
reverse transcriptase, BSA, dATP, dCTP, dGTP, and dUP. 
PCR was then performed as follows: 
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1.10 t1 of the completed 1st-strand cDNA reaction product in a 0.5 ml PCR tube 
was heated to 90°C for 5 min and then chilled on ice. 
2.5 µl of 10 x PCR buffer (100 mM Tris-Cl (pH 8.3), 500 mM KC1,25 mM 
MgC129 0.01% gelatin), 1 p. 1 of each PCR primers (see below) and 32.8 µl H2O 
were added. 
3. The sample was heated to 80°C for 2 min. 
4.0.2 µl of AmpliTaq DNA polymerase (5 units/pi) was then added, followed by a 
drop of mineral oil. 
5. PCR was set for 25 thermal cycles of 94°C for 1 min, 55°C for 1 min and 72°C 
for 2.5 min in a DNA Thermal Cycler. 
6. After completion, the PCR product was analysed in a 1.2% agarose gel in 0.5 x 
TBE buffer (Table 2-7). 
In this study two degenerate PCR primers (295 ng/pl in H2O) used were 
5' -CTCACC(/G)TGCATA(/C)AGCGTGCA-3' and 
5' -C(/G)TC(/G)TG(/C)CCCT(/G)GCCAGGAAGTA-3' . 
2.9.3 Cloning 
After PCR amplification, the cDNA of interest was cloned into the vector pCRTMH 
using Invitrogen's TA Cloning System (version 1.3). Ligation was performed as 
follows: in a tube containing 1 µl of lOx ligation buffer (Table 2-7) and S µl of H20,1 
µl of PCR product, 2W of vector pCRTMII (25 ng/p. l) and 1 tl of T4 DNA ligase (4 
units/W) were added and the reaction carried out at 12°C overnight. 1 t1 of the 
completed ligation product was added to a tube containing 2 µl of 0.5 M ß- 
mercaptoethanol and 50 µl of competent E. coil INVaF' cells and incubated on ice for 
30 min. The sample was heat-shocked at 42°C for exactly 45 sec, followed by 
incubation on ice for further 2 min. After addition of 450 µl of pre-warmed SOC 
medium (Table 2-7), the sample was incubated at 37°C for 1 hour at 225 rpm in a 
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shaker-incubator. 25 µl and 100 µl of the sample were spread on separate LB agar 
plates containing ampicillin (50 p. g/ml) and 5-bromo-4-chloro-3-indolyl-D-galactoside 
(X-Gal: 1 mg/plate) and the plates were incubated at 37°C overnight. White colonies 
were picked and grown up in LB medium (Table 2-7) containing ampicillin (50 tg/ml) 
at 37°C overnight at 225 rpm in a shaker-incubator for plasmid isolation. 
A small scale plasmid DNA preparation was performed according to the method 
described by Sambrook, et al (Sambrook et al. 1989). 1.5 ml of overnight bacterial 
culture were centrifuged (12000 g, 4°C, 30 sec) and the bacterial pellet was 
resuspended in 100 tl of solution I (Table 2-7) and alkalytically lysed by adding 200 tl 
of solution 11 (Table 2-7) and incubating on ice for 3 min. The sample was neutralized 
by adding 150 µl of solution III (Table 2-7) and by subsequent centrifugation (12,000 
g, 4°C, 5 min). The supernatant was further deproteinized by adding an equal volume 
of phenol: chloroform: isoamyl alcohol (25: 24: 1) and centrifuging at 4°C for 2 min at 
12000 g. Supernatant was collected and its DNA was precipitated by adding two 
volume of ethanol and incubating at room temperature for 2 min. After centrifugation 
(12,000 g, 4°C, 5 min) and removal of supernatant, the DNA pellet was washed with 
70% ethanol, dried under vacuum for 10 min and dissolved in 20 µ1 of TE buffer 
(Table 2-7). DNA concentrations were measured in a mini-DNA/RNA spectrometer. 
The obtained plasmid DNA was then subject to restriction enzyme analysis. In this 
study, restriction enzyme EcoRI was used to cut both ends of the insert in the pCR'II 
vector. 1 p. g of the plasmid DNA was cut by 10 units of EcoRl in a total volume of 20 
p1 in the Gibco REact® 3 buffer (Table 2-7) at 37°C for 1 hour. After heat-inactivation 
(75°C, 10 min), the sample was run in a 1% agarose gel in 0.5x TBE buffer. 
After confirmation of the insert in pCRTMII vector, a midi-scale of plasmid DNA 
preparation was carried out using the QIAGEN Plasmid Midi Kit to yield - 100 µg of 
pure plasmid DNA for use in further experiments. 50 ml of overnight bacterial culture 
were centrifuged (6,000 g, 4°C, 10 min) and the pellet was resuspended in 4 ml of 
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buffer P1 (Table 2-7), alkalytically lysed by adding 4 ml of buffer P2 (Table 2-7) and 
incubating at room temperature for 5 min. The sample was neutralized by adding 4 ml 
of chilled buffer P3 (Table 2-7) and incubating on ice for 15 min, followed by 
centrifuging at 4°C for 30 min at 30,000 g. The supernatant was promptly collected and 
passed through a QIAGEN-tip 100 by gravity, which had been equilibrated with 4 ml 
of buffer QBT (Table 2-7). The tip was washed with 2x 10 ml of buffer QC (Table 2- 
7) and the plasmid DNA eluted with 5 ml of buffer QF (Table 2-7). The DNA in buffer 
QF was then precipitated by adding 0.7 volumes of isopropanol and centrifuging at 4°C 
for 30 min at 15,000 g. The DNA pellet was washed with 5 ml of 70% ethanol, dried 
under vacuum for 10 min and dissolved in 100 µl of TE buffer. 
2.9.4 DNA Sequencing 
The insert in the pCRI14Ill vector was sequenced by chain-termination method using the 
USB Sequenase Version 2.0 DNA Sequencing Kit. Plasmid DNA (4 µg) was 
denatured by adding 0.1 volumes of 2M NaOH, 2 mM EDTA and incubating 30 min at 
37°C (Lim & Pene 1988). The mixture was neutralized by adding 0.1 volumes of 3M 
Na-acetate (pH 5.2) and the DNA precipitated with 3 volumes of ethanol (-70°C, 15 
min). The pelleted DNA was washed with 70% ethanol, vacuum-dried and dissolved in 
7W H2O, to which 2 µl of Sequenase Reaction Buffer and 1 pl of sequencing primer 
were added. This DNA mixture was heated to 65°C for 2 min and then cooled slowly to 
< 35°C over 20 min. The labelling reaction was done by adding 1 µl of 0.1 M DTT, 2 
µl of labeling mix of dGTP, dCTP and dTTP (all 1.5 µM), 0.5 µl of [35S]dATP (10 
pCi/µl or 1000 Ci/mmol), and 2 µl of Sequenase Polymerase (1.6 units/µl) to the DNA 
mixture. After incubation at room temperature for 5 min, the labelling reaction was 
terminated by transferring 3.5 µl of labelling reaction to each termination tube 
containing 2.5 µl of either of ddATP, ddGTP, ddCTP and ddTTP (all 8 µM) and 
incubating at 37°C for 5 min. The termination reaction was stopped by adding 4 µl of 
stop buffer (Table 2-7). The completed samples were heated to 94°C for 1 min 
immediately before loading onto 6% polyacrylamide sequencing gel (Table 2-7) at 2W 
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per lane. The gel was run in lx TBE buffer under constant power of 45 W. After 
electrophoresis the gel was dried at 80°C under vacuum for 2 hours and exposed to 
Hyperfilm-MP films at room temperature for -- 2 days. 
Table 2-7. Solutions, medium and gel used for molecular cloning * 
TBE buffer 89 mm Tris-base 
89 mm boric acid 
2 mm EDTA 
lOx ligation buffer 60 mm Tris-Cl (pH 7.5) 
60 mm MgC12 
50 mM NaCl 
0.1 % BSA 
70 mm ß-mercaptoethanol 
1 mM ATP 
20 mM DTT 
10 mm spennidine 
SOC medium 2 % tryptone 
0.5 % yeast extract 
10 mm NaCI 
2.5 mm KCI 
10 mM MgC12 
10 mM MgSO4 
20 mm D-glucose 
(continued) 
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Table 2-7. Solutions, medium and gel used for molecular cloning * (continued) 
LB medium 1 % tryptone 
0.5 % yeast extract 
0.5 % NaCl 
1 mm NaOH 
solution I 25 mM Tris-Cl (pH 8) 
50 mM glucose 
10 mm EDTA 
solution II 0.2 M NaOH 
1 % SDS 
solution III 3 M K-acetate 
11.5 % v/v glacial acetic acid 
TE buffer 10 mm Tris-Cl (pH 8) 
1 mm EUM 
REact 3 buffer 50 mm Tris-Cl (pH 8) 
10 mM MgC12 
100 mM NaCI 
buffer P1 50 mM Tris-CI (pH 8) 
10 mm EDTA 
100 . tg/ml RNase A 
buffer P2 0.2 M NaOH 
1 9'o SDS 
(continued) 
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Table 2-7. Solutions, medium and gel used for molecular cloning * (continued) 
buffer P3 3 M K-acetate (pH 5.5) 
buffer QBT 750 mM NaCl 
50 mm MOPS (pH 7) 
15 % ethanol 
0.15 % Triton X-100 
buffer QC 1 M NaCl 
50 mm MOPS (pH 7) 
15 % ethanol 
buffer QF 1.25 M NaCl 
50 mm Tris-Cl (pH 8.5) 
15 % ethanol 
stop buffer 95 9'o formamide 
20 mm EDTA 
0.05 % bromophenol Blue 
0.05 % xylene cyanol FF 
50 ml DNA sequencing gel 10 ml 5x TBE buffer 
6 ml 50% long ranger gel solution 
21 g urea 
x ml H2O (bringing to 50 ml) 
500 
.d 10% APS 
12.5 µl 1EMFD 
*: Items are ordered as appeared in the text. 
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2.10 Real-time Dynamic Bioluminescence Measurements of ATP Release 
Pituitary glands were enzymatically dispersed in Ca2+-free HBSS containing 0.3% 
BSA, 1 mg/ml collagenase, 25 µg/ml DNase and 10 mM HEPES, as described above. 
Approximately 2x 105 cells were plated out in a plastic vial with a2 cm2 surface area 
and cultured under medium M199 supplemented with 5% FBS, 5% horse serum, 100 
unit/ml penicillin, 100 tg/ml streptomycin and 2 mM glutamine at 37°C in a water- 
saturated atmosphere of 5% CO2 in air. Real-time dynamic bioluminescence 
measurements of ATP release on attached cells was performed on the basis of 
luciferase-catalyzed oxidation of D-luciferin (ATP + luciferin + 02 luciferase > 
oxyluciferin + AMP + PPi + CO2 + light) (Strehler & McElroy 1957). The method 
used here was modified from that described by White (White 1977) using a 1250 
Luminometer (Bio-Orbit Oy, Turku, Finland). After 2 days in culture, cells were 
thoroughly washed in aqueous 137 mM NaCl containing 5 mM KCI, 4 mM CaCl2,2 
mM MgSO41 0.4 mM KH2PO4,3 mM Na2HPO4,4 mM NaHCO31 10 mM glucose, 
10 mM HEPES (pH 7.4) and 1% BSA (henceforth referred to as ATP assay buffer). 
Then cells were bathed in 190 µl ATP assay buffer containing highly purified firefly 
luciferase and synthetic D-luciferin at the final concentrations of 75 and 150 µg/ml, 
respectively, for 20 min before luminescence measurements at room temperature. 
Concentrated stimulators or reagents in a volume of 10 µl were very gently added to 
cells through a 200 µl pipette tip. No luminescence measurement was made during the 
addition as indicated in illustrations. Emitted light was integrated for 1 second periods 
and continuously recorded. 
2.11 Animals 
Sprague-Dawley rats on days 18-20 of pregnancy were provided by the Department of 
Comparative Biology, Charing Cross Hospital, London and the Medical School, 
University of Bristol, Bristol. Wistar rats were provided by the Medical School, 
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University of Bristol, Bristol and the Institute for Hormone and Fertility Research, 
Hamburg, Germany. 
2.12 Materials 
Specific materials including instruments were listed in Table 2-8 and other unlisted 
reagents used in this study were purchased from Sigma, unless otherwise specified. 




dispase II Boehringer 
DMEM, DMEM/F12, M199, HBSS, FCS, 
horse serum, fungizone Gibco 
Calcium ion imaging 
Fura-2 AM Cambridge Bioscience 
glass coverslips Raymond A Lamb 
MagiCal system, `rests' software Applied Imaging 
Immunocytochemistry 
antibodies of anti-MAP 1 and anti-NSE Cambridge Bioscience 
DPX mountant Raymond A Lamb 
(continued) 
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Table 2-8. Specific materials used (continued) 
Mated Suppliers* 
normal rabbit serum, normal swine serum, 
biotinylated rabbit anti-mouse IgG, 
swine anti-rabbit IgG Dako 
Superfusion of Cells 
fraction collector Isco 
LH RIA 
LH standard, anti-LH antibody, rat LH (for iodination) NIDDK 
normal rabbit serum, 1% donkey anti-rabbit serum Scottish Antibody 
cAMP and cGMP assay 
cAMP, cGMP RIA kits IBL 
Western Immunoblotting of PKC 
Boehringer Block Reagent Boehringer 
Ponceau S, peroxidase-conjugated goat-anti-rabbit IgG Sigma 
protein electrotransfer Hoefer 
protein gel facilities Pharmacia 
Rainbow" coloured protein molecular weight markers, 
a polyvinylidene difluoride membrane, ECL kit Amersham 
Serva Blue G Serva 
specific polyclonal rabbit anti-PKCa, PKC1 and PKCe Gibco 
(continued) 
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Table 2-8. Specific materials used (continued) 
Materials Suppliers* 
Molecular Cloning 
1st-strand cDNA synthesis kit, DNAIRNA spectrometer Pharmacia 
DNA sequencing gel facility 
EcoRI, REact 3 buffer 
International Biotech 
Gibco 
gel dryer Bio-Rad 
long ranger gel stock solution AT Biochem 
QIAGEN Plasmid Midi Kit QIAGEN 
Poly(A) Quik mRNA Isolation column Stratagene 
RNAzoITM B Biotecx 
[35S]dATP Du Pont 
TA Cloning System Invitrogen 
Taq DNA polymerase, mineral oil, DNA Thermal Cycler Perkin-Elmer 
USB Sequenase Version 2.0 DNA Sequencing Kit, 
Hyperfilm-MP film Amersham 
Other Chemicals 
A23187 Calbiochem 
C-type natriuretic peptide (CNP) Bissendorf 
ethanol, methanol, ether Merck 
2-methylthioATP, ßyy-methylene ATP RBI 
phenol: chloroform: isoamyl alcohol (25: 24: 1) Sigma 







Amersham International p1c., Buckinghamshire, UK 
Applied Imaging International Ltd., Sunderland, UK 
AT Biochem, Malvern, PA, USA 
Bayer plc, Berkshire, UK 
Bio-Rad Laboratories Ltd., Hertfordshire, UK 
Biotecx Laboratories, Inc., Houston, Texas, USA 
Bissendorf Biochemicals, Hannover, Germany 
Boehringer-Mannheim UK Ltd., East Sussex, UK 
Calbiochem (Calbiochem-Novabiochem) (UK) Ltd., Beeston, Nottingham, UK 
Cambridge Bioscience, Cambridge, UK 
Dako Ltd., High Wycombe, Bucks, UK 
Du Pont (UK) Ltd., Stevenage, Hertfordshire, UK 
Gibco BRL Life Technologies, Paisley, UK 
Hoefer Scientific Instruments, San Francisco, USA 
IBL, Hamburg, Germany 
International Biotech Inc., New Heaven, CT, USA 
Invitrogen Corp., San Diego, CA, USA 
Isco Inc., Lincoln, NE, USA 
Merck Ltd., Lutterworth, Leics, UK 
NIDDK, National Institute of Diabetes, Digestive and Kidney Diseases, MD, USA 
Perkin-Elmer Corp., Norwalk, CT, USA 
Pharmacia Biotech, St. Albans, Herts, UK 
QIAGEN Ltd., Surrey, UK 
Raymond A Lamb, London 
RBI (Research Biochemicals International), Natick, MA, USA 
Saxon Biochemicals GmbH, Hannover, Germany 
Serva Biochemicals, Heidelberg, Germany 
Scottish Antibody Production Unit, Carluke, Lanarkshire, UK 
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Sigma Chemical Company Ltd., Poole, Dorset, UK 
Stratagene Ltd., Cambridge, UK 
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Chapter 3. ATP RECEPTORS IN RAT HYPOTHALAMIC NEURONS 
Introduction 
Accumulated evidence has suggested that ATP may act as a transmitter or co-transmitter 
in both peripheral and central nervous system (Burnstock 1972, Burnstock 1990, 
Edwards et al. 1992). ATP has been shown to activate currents in a variety of cell 
preparations including cardiovascular muscle (Benham & Tsien 1987, Friel & Bean 
1988), visceral muscle (Friel 1988), skeletal muscle (Hume & Honig 1986), sensory 
neurons (Jahr & Jessell 1983, Krishtal et al. 1983, Krishtal et al. 1988, Bean 1990), 
and neurons derived from the locus coeruleus (Tschopl et al. 1992) and the nucleus 
tractus solitarius (Ueno et al. 1992a). ATP mimics the effect of nerve stimulation on 
many smooth muscles (Burnstock et al. 1970, Hoyle et al. 1990, von Kugelgen et 
al. 1990) and excites rat medulla oblongata vasomotor neurons in vivo (Sun et al. 
1992). ATP-mediated fast excitatory synaptic transmission has also recently been 
recorded in guinea-pig coeliac neurons and in rat medial habenula neurons (Evans et 
al. 1992, Silinsky et al. 1992, Edwards et al. 1992). 
ATP induces inositol phosphate accumulation and intracellular calcium mobilization in 
many non-neuronal cell types and neuroblastoma cell lines (Ehrlich et al. 1988, Neary 
et al. 1991, Christie et at. 1992, Gerwins & Fredholm 1992, Kastritsis et al. 1992, 
Iredale et al. 1992a) but little is known about ATP receptor-mediated intracellular 
signaling in neurons of the central nervous system. The present study was to examine 
whether ATP could be a potential and genuine transmitter in hypothalamic neuron 
transmission and if so, how intracellular Ca2+ signalling was conducted. 
Methods 
After a total of 8 to 15 days in culture, rat hypothalamic neurons were subject to 
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calcium ion imaging at the single cell level. Ligands were dissolved in water or ethanol 
and DMSO, and diluted in an appropriate buffer before use, giving final solvent 
concentrations of <0.05% and <0.01% respectively, at which level they were shown to 
have no detectable effects on [Ca2+]1 when used alone. As data collection time was 
limited by image processor memory, ligands were added to cells in a heated chamber 
containing 600 or 800 µl solution by bolus addition of 150 or 200 µl of 5x concentrated 
solution through a 200µL pipette tip at a fixed position approximately 6 mm away from 
the studied cell, rather than by superfusion. Final concentrations of ligands in the 
solution, rather than 5x stock ligand concentrations are referred to in the text. Ca2+-free 
solution was made by omitting CaCl2 and adding 0.1 mM EGTA to Ca2+ buffer. The 
osmolarity of all solutions were adjusted to 290 to 300 mOsm and pH 7.4. All cells 
were shown to respond to other neurotransmitters such as NMDA and kainic acid, and 
to K+ (56 mM) at the end of each experiment to confirm, viability. Before and between 
additions, cells were superfused for z 20 min at 1 ml/min with pre-warmed buffer. 
To confirm that cells examined were of neuronal origin, the presence of the neuron- 
specific markers microtubule-associated protein 1 and neuron specific enolase were 
determined immunocytochemicaüy and shown in Figure 3-1. 
Results 
ATP-induced Intracellular Cat' response 
Addition of 100 µM ATP produced a rapid and transient increase in [Ca2+]i in a 
subpopulation (42%) of total 732 cultured rat hypothalamic neurons examined (Figure 
3-2a). An approximately 8-fold increase in [Ca2+]; from a resting level of 163 ± 9.4 nM 
to a maximum of 1231 ± 88 nM (Means ± SE, n= 96 cells with the initial exposure 
only to 100 µM ATP) was observed (Figure 3-2b). [Ca2+]; peaked around 12 s (12 t 







Figure 3-1. Hypothalamic neurons and their neural network formation in primary rat ! octal 
hypothalamic neuronal cultures maintained 10 days. (A) Hypothalamic neurons viewed through phase 
contrast optics. (B) and (C) Immunocytochemical localization of neuronal specific markers, microtubule- 
associated proteins 1 (MAPI, 1: 500 dilution) and neuron-specific enolase (NSE, 1: 400 dilution), 
respectively. Primary antibodies were replaced with normal rabbit serum (1: 100 dilution) for controls 
(not shown). (D) Hypothalamic neurons loaded with Fura-2 and excited by 340 nm UV light viewed 




























Figure 3-2. The effects of ATP on [Ca2+]i. (a) Showing a typical Ca2+i recording from a single 
hypothalamic cell exposed to 100 pM ATP. The addition of ATP is indicated by the arrow. (b) The temporal 
effect of ATP (100 µM) on [Ca2+]i in rat hypothalamic neurons (mean ± SE: n= 96). The introduction of 
ATP is indicated by the arrow. (c) ATP dose/response curve (mean ± S. E: n= 11). Cells were exposed 
consecutively to 1,10,50,100,500 and 1000 pM ATP for 3 min at each concentration with 30 min 







near resting levels after 3 min (230 ± 28 nM, n= 96). The ATP-induced response was 
dose-dependent from 1 and 500 p. M (Figure 3-2c) and was detectable within 
approximately 200 ms of ligand addition (n = 9: using image capturing at 25Hz, i. e. 
one frame of image per 40 ms). 
Adenosine, AMP, ADP and GTP at 100 - 200 pM did not produce a detectable increase 
in [Caz+]; (n = 22: Figure 3-3). a, p-methylene ATP (a slow hydrolysable ATP 
analogue) induced a rapid, suramin-sensitive increase in [Ca2+]i to approximately half 
the maximum of equimolar ATP (47 ±6% at 100 µM: n= 11). Both 3-thio-ATP 
(ATPyS -a slow hydrolysable ATP analogue) and ß, -&imido-ATP (AMP-PNP - an 
unhydrolyzable ATP analogue) evoked Cat+; responses similar to those induced by 
equimolar ATP (n = 13: Figure 3-4). 
Sources of ATP-induced [Ca211 increase 
In the absence of extracellular Ca2+ the 100 µM ATP-induced response was abolished 
(n = 20: Figure 3-5a). The addition of cadmium (50 µM) completely but reversibly 
inhibited the [Ca2+]; increase in response to 100 µM ATP and, when added 
immediately after ATP, rapidly reduced the ATP-induced [Ca2+]i increase to near 
resting levels (n = 29: Figure 3-5b). Nifedipine at 10 µM (but not 1 µM) inhibited 
maximal ATP-induced [Ca2+]; increase by 62 ± 5% (n = 11: Figure 3-6). Nickel at 50 
µM had no effect on the 100 pM ATP-induced response but at 200 pM slightly reduced 
the response (by 20 ± 4.8% of the maximum [Ca2+]i: n= 24). Pretreatment with 
ryanodine (50 pM) for 2-15 min had no effect on the response (n = 17), neither did the 
addition of w-conotoxin GVIA (5 to 75 pM, n= 19). 
Effect of suramin and other neurotransmitter receptor antagonists on 
ATP-Induced Cat+1 response 
Suramin, a P2-purinoceptor antagonist, had no affect on resting [Ca2+]; in 
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hypothalamic neurons but reversibly inhibited the ATP-induced Cat+1 response in a 
dose-dependent manner (ID50 = 25 µM: Figure 3-7a). At a concentration of 100 µM, 
suramin almost abolished the effect of equimolar Al? (n = 35: Figure 3-7b). In 
contrast, pretreatment with suramin had no effect on 5-HT-, acetylcholine-, 
noradrenaline- or glutamate-receptor agonists-induced increase in [Ca2']i in cultured 
hypothalamic neurons (n =4M 24: Figure 3-8). 
Atropine, hexamethonium, ketanserin, bicuculline, DL-2-amino-5-phosphonovaleric 
acid (AP-5, an NMDA glutamate receptor antagonist), 6,7-dinitroquinoxaline-2,3-dione 
(DNQX, non-NMDA glutamate receptor antagonist) and 8-cyclopentyltheophylline 
(CPDMX, adenosine receptor antagonist) did not significantly affect the ATP-induced 
Cat+i increase (n =9- 19: Figure 3-9). 
Discussion 
Extracellular ATP-provoked intracellular Ca2+ responses in cultured hypothalamic 
neurons are highly specific, as: 1) adenosine, AMP, ADP and GTP failed to elicit a 
response (Figure 3-3); 2) antagonists of muscarinic, nicotinic, NMDA, non-NMDA, 
GABA, 5HT and adenosine receptors had no effects on the ATP-induced Cat+i 
responses (Figure 3-9); 3) the ATP-induced Cat+i responses were blocked by suramin 
(Figure 3-7), a P2-purinoceptor antagonist (Dunn & Blakeley 1988, von Kugelgen et 
al. 1990, Hoyle et aA 1990, Nakazawa et al. 1990b); and 4) suramin had no effect 
on 5-HT-, acetylcholine-, noradrenaline- or glutamate-receptor agonists-induced 
increase in (Ca2+]i (Figure 3-8). These results pharmacologically demonstrated the 
presence of a receptor specific for ATP in cultured hypothalamic neurons. 
The present study indicates that only a subpopulation of hypothalamic neurons express 
ATP receptors since an ATP-induced Ca2+ response occurred in 42% of hypothalamic 
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Figure 3-3. Effects of adenosine and other nucleotides on [Ca2+]i in ATP-responsive cells. 
Representative recordings were made from two individual cells: 100 NM ATP was used. (a) The absence of 
Ca2+i response to adenosine (200 pM. (b) The absence of Ca2+i response to AMP, ADP and GTP (all 100 
MM). The 6gand additions are indicated by the arrows. 
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Figure 3-4. Effects of Al? analogues on [Ca2+]i. A representative recording from a single hypothalamic 
neuron exposed sequentially to ATP, 3-thio-ATP (ATPyS) and P, y imido-ATP (AMP-PNP) with 30 min 
washouts between recordings. The point of ligand additions are indicated by the arrows. 




















Figure 3-5. The effects of extrac ellular Ca2+ and cadmium on ATP-induced [Ca2+]i increase in rat 
hypothalamic neurons. Representative traces were recorded from 2 individual cells and 100 NM ATP used 
with 30 min washouts between recordings. (a) Following removal of extracellular Ca2+ by perfusion with 
Ca2+-free, 0.1 mM EGTA-contsiniag buffs for 5 min, the ATP-induced [Ca2+]i increase was abolished. 
(b) The addition of cadmium (50 MM) completely but reversibly blocked the Ca2+i response to Al?, and 
when added after ATP stimulation, accelerated [Ca2+]i return to baseline (b: right hand panel). The 
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3-6. A representative example of the inhibitory effect of nifedipine on ATP (100 uM)- 
induced [Ca2+]i increase in a hypothalamic cell with 30 min washouts between recordings. The 
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Figure 3-7. (a) Dose-dependent inhibition of ATP (100 µM)-induced Cat+i response by suramin 
(mean ± SE n2 13). (b) Su amin (100 IM)-induced revel ible inhibition of the Ca2+i response to 
100pM ATP in a single rat hypothalamic neuron. A 30 min washout separates the r cordings. 1U 
additions of ligands are indicated by arrow. 
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Figure 3-8. The lack of effect of sucamin on 5HT, acetylcholine, nocadrenaline and glutamate 
receptor activity in rat hypothalamic cells. Representative traces were recorded from 5 individual 
cells (a-e). The same agonists were applied twice, firstly in the absence of and subsequently in the 
presence of 100 µM suramin with 30 min washouts between recordings. The concentrations of 
agonists used were: (a) 5HT 100 µM, (b) cytisine 10 µM (nicotinic receptor agonist), (c) 
nocadrenaline 100 NM, (d) NMDA 10 µM, & (e) kainic acid 1 pM (non-NMDA receptor agonist). 



























Figure 3-9. The lack of effect of acetylcholine, SHT, GABA, glutmaate and adenosine receptor 
antagonists on ATP-induced Cat+i response in at hypothalamic cells. Representative traces were 
obtained from 7 individual cells (a-g). ATP (100 NM) was applied twice, firstly in the absence of and 
subsequently in the presence of the various antagonists with 30 min washouts between recordings. 
Doses used were: (a) atropine 100 pM; (b) hexamethonium 100 pM; (c) ketanserin I pM; (d) 
bicuculline 50 pM; (e) DL-2-amino-5-phosphouovaleric acid (AP-5) 100 µM; (f) 6,7- 
dinitmquinoxaline-2,3-dione (DNQX) 100 NM; and (g) 8-cyclopentyltheophylline (CPDMX) 100 
NM. The additions of the antagonists and Al? are indicated by arrows. 
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other neurotransmitters (such as NMDA and kainic acid) and to depolarization by high 
concentration of K+, excluding impaired cell viability as an explanation for response 
failure. The work from other investigators showed similar ATP-responsive 
subpopulation in vertebrate sensory neurons, hippocampal neurons and intracardiac 
neurons (Jahr & Jessell 1983, Krishtal et al. 1983, Bean 1990, Allen & Burnstock 
1990, Inoue et al. 1992). 
As the observed ATP-induced [Ca2+]; increase was abolished by both removal of 
extracellular Caz+ and by cadmium, which blocks high voltage-activated (HVA) Ca2+ 
channels, Ca2+ influx appears to be responsible for the ATP-induced [Ca2+]; increase in 
rat hypothalamic neurons. This is further supported by the lack of effect of ryanodine, 
an intracellular Ca 2+ release inhibitor, on ATP-induced [Ca2+]; increase. 
Electrophysiological experiments have shown that HVA Ca 2+ currents in rat 
hypothalamic neurons are completely blocked by 10. tM cadmium (Müller et al. 1992), 
whereas ATP-gated Ca2+ currents in muscle cells are unaffected by up to 500 . tM 
cadmium (Benham & Tsien 1987, Thomas & Hume 1990) (although they can be 
blocked at much higher levels (5 mM) (Thomas & Hume 1990)). In contrast, low 
voltage-activated (LVA) Ca2+ currents in hypothalamic neurons are strongly inhibited 
by 50 µM nickel (Müller et al. 1992). In the present study, complete inhibition of 
ATP-induced Ca2+ response by 50 µM cadmium with 20% inhibition by nickel 
suggests that Ca2+ entry through HVA channels is most likely to be responsible for the 
observed ATP-induced [Ca2+]; increase in rat hypothalamic neurons. The lack of effect 
of W-conotoxin GVIA, and inhibition of ATP-induced [Ca2+]; increase by nifedipine 
(albeit by only 62% at 10 pM - in keeping with the findings from electrophysiological 
experiments (Müller et al. 1992)) suggests that 'L'- rather than 'N- type HVA Caz+ 
channels predominate. The present findings of intracellular Ca2+ signaling in 
hypothalamic neurons are similar to those observed in cardiac myocytes (Danziger et 
al. 1988, De Young & Scarpa 1989, Christie et al. 1992), but differs from the 
findings in a neuroblastoma cell line in which mobilization of Ca2+ solely from 
intracellular stores is responsible for an increase in [Ca2+]; (Iredale et al. 1992a, 
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Iredale et aL 1992b). 
As the observed Ca2+ response in hypothalamic neurons was rapid, which could be 
seen within approximately 200 ms after ligand addition, and no evidence was found in 
this study to indicate the involvement of intracellular Ca2+ mobilization from 
intracellular Ca2+ stores, the ATP receptor found in hypothalamic neurons appears to 
fall into the ATP-gated ion channel subtype of P2 purinoceptor (i. e. P2X subtype). 
Because a full range of ATP receptor agonists has not been tested in this study, the 
subtype of this receptor is not clear. As discussed above, the ATP-induced increase in 
[Ca2+]; in hypothalamic neurons is caused by Ca2+ influx via Ca2+ channels. It seems 
that activation of these ATP receptors lead to cell depolarization and this membrane 
depolarization then causes opening of Ca2+ channels. 
The permeability of ATP-gated channels to cation varies with cell types. In both arterial 
muscle cells (Benham & Tsien 1987) and rat nucleus solitarii neurons (Ueno et al. 
1992a) Ca2+ is more permeable in ATP-activated channels than Na+, while in sensory 
neurons (Jahr & Jessell 1983, Krishtal et al. 1988, Bean et al. 1990) Na+ is a 
predominant ion through ATP-activated channels. Inferred from the present study 
based on intracellular Ca2+ imaging, the hypothalamic Al? receptor appears not to be 
very permeable to Cat+. The present study is, however, unable to rule out a 
contribution to the increase in [Ca2+]i by Ca2* entry through ATP-activated ion 
channels. 
It has been proposed that protein phosphorylation by ecto-protein kinase might initiate 
the ATP-induced response (Zhang et al. 1988, Ehrlich et al. 1990, Christie et al. 
1992). This would imply that hydrolysable ATP should be required for ATP-induced 
responses. The present results, together with the findings of others (Benham & Tsien 
1987, Iredale et al. 1992a, Sun et al. 1992, Weiss et al. 1992), however, do not 
support this view as the very slowly hydrolysable ATP analogue ATPyS and the non- 
hydrolysable analogue ß, ßr-imido-ATP (AMP-PNP) were as efficient as ATP in eliciting 
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currents or a [Ca2+]; increase (Figure 3-4). 
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Chapter 4. PITUITARY ATP RECEPTORS: PHARMACOLOGICAL 
CHARACTERIZATION, FUNCTIONAL LOCALIZATION, 
CLONING AND SEQUENCING 
Introduction 
Extracellular ATP is now known to mediate a variety of responses in a number of 
biological systems via ATP receptors (P2 purinoceptors). In pituitary cell cultures, ATP 
was shown to strongly stimulate inositol phosphate accumulation (Davidson et al. 
1990) and this effect appeared to be mediated by P2U subtype of ATP receptors. No 
significant pituitary hormone release in response to ATP was, however, observed in 
this early investigation. Thus, it was concluded that none of the function-specific 
pituitary cell types, i. e. lactotropes, somatotropes, gonadotropes, corticotropes or 
thyrotropes, was direct targets for ATP action. Although this conclusion is logical from 
this data, it renders difficult the interpretation of the ATP-induced inositol phosphate 
signaling, which was actually much stronger than that induced by specific releasing 
hormones such as thyrotropin-releasing hormone (TRH) and gonadotropin-releasing 
hormone (GnRH). Considering the limitation of the techniques employed by this early 
investigation, the present study was to re-examine ATP receptors in pituitary cells using 
sensitive modern techniques such as real-time calcium ion imaging of Fura-2 
fluorescence at a single cell level and molecular cloning. 
Methods 
primary pituitary cells were cultured from adult female Wistar rats (approximately 150 
g). After 1 day and after 2 to 3 days in culture rat pituitary cells and aT3-1 cells, 
respectively, were loaded with 2 µM Fura-2 AM at 37°C for 30 min and real time digital 
calcium ion imaging was performed at 35°C. Cells were exposed to ligand by rapidly 
pipetting 2.5 ml of medium containing the stimulus into the recording chamber which 
was maintained at approximately 0.5 ml by means of an aspiration tube positioned 2 
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mm above the coverslip. Cells with a clear Ca2+ response (i. e. those in which 
stimulation at least doubled the [Ca2+j; ) were defined as 'ligand-responsive' and used 
to generate the data shown. All experiments were repeated on at least three occasions 
and data shown are either from a single representative experiment or are pooled from 
multiple experiments as described. 
Total RNA was extracted from adult Wistar rats of either sex and molecular cloning 
was performed as described in Chapter 2. 
Results 
Intracellular Ca2+ Responses 
ATP (100 µM) rapidly increases cytosolic Ca 2+ in approximately 30% of 1765 rat 
pituitary cells in primary culture. GnRH (100 nM) increased [Ca2+]; in 9% of the cells 
in this heterogeneous population and of these, 82% also responded to ATP (10 to 100 
µM). The cells which responded to ATP and GnRH were not responsive to 
corticotropin-releasing hormone (CRH), growth hormone releasing hormone (GRH) 
and TRH (Figure 4-la). Thus, it is clear that GnRH responsive gonadotropes are 
responsive to ATP. This identification of gonadotropes as major targets for ATP action 
is further confirmed by studies on cells from the gonadotrope derived aT3-1 cell line 
(Windle et al. 1990, McArdle et al. 1992) which respond both to GnRH and ATP as 
described below. 
In gonadotropes, 100 tM ATP induced a rapid 7-fold increase in [Ca2+j; from a 
baseline of 132 ± 20 nM to the maximum of 896 ± 95 nM (Mean ± SE: n= 28 
previously unstimulated cells), followed by a plateau phase, returning from 200 - 500 
nM to baseline over approximately 4 minutes. The Cat+; response was concentration- 
dependent between 0.1 and 100. tM of ATP (Figure 4-1b), and in the absence of 
extracellular Ca2+ the plateau phase only was attenuated (Figure 4-1c), indicating that 
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Figure 4-1. ATP-induced cytosolic Ca2+ responses in gonadotropes. (a) Representative recording 
showing the effect of ATP on cytosolic Ca2+ in a single rat pituitary cell functionally characterized as a 
gonadotrope. The successive stimulations with ATP (100 pM), CRH (100 nM), GRH (100 nM), GnRH 
(100 nM), TRH (100 nM) and KCl (40 mM) were separated by washouts periods of 2- 30 min. (b) 
Concentration dependence of the ATP-induced Ca2+ response in a gonadotrope successively stimulated 
with 0.01-100 pM ATP. Each washout period between the stimulations was 20 min. (c) Recording from a 
single gonadotrope showing intracellular Ca2+ mobilization. The cell was stimulated first in Ca2+-free 
medium containing 0.1 mM EGTA as indicated by the bar and then in normal Cat+-containing medium. 20 
min of washouts separated the stimulations. 
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Cat+; spike. A similar Cat+; response was produced by equimolar UTP and ADP, 
whereas UDP (100. tM) caused a modest increase in [Ca2+]; and GTP (100 µM) had 
only a very small stimulatory effect. Adenosine, AMP, GDP, UMP, CDP and CTP (all 
at 100 pM) were ineffective. 
Suramin, a selective P2-purinoceptor antagonist, had no effect on GnRH-induced 
[Ca2+]; increase but reversibly reduced the maximal ATP-induced [Ca2+]; response in 
gonadotropes (Figure 4-2a) and aT3-1 cells (not shown) by approximately 40% (mean 
± SEM: 41 ± 20%: n=5 cells) and 60% (61 ± 5%: n= 43 cells), respectively. The P2X 
receptor agonists ß, y-methylene ATP and a, ß-methylene ATP (both 100 µM) did not 
increase cytosolic Ca 2+ in gonadotropes (Figure 4-2b) or aT3-1 cells (not shown), 
whereas the P2y receptor agonist 2-methylthioATP had only a modest stimulatory effect 
in both cell types (Figure 4-2b and data not shown). 
In aT3-1 cells, ATP, ADP and UTP all increased cytosolic Ca2+ with comparable 
potency and efficacy (Figure 4-3). 
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Figure 4-2. Effects of P2-purinoceptor antagonist and d agonists on [Ca2+]i in gonadotropes. (a) 
Representative recording from a single gonadotrope showing the effect of the P2 receptor antagonist 
suramin on ATP-induced Ca2+i response. The application of suramin is indicated by the bar and the 
stimulations were separated by washouts periods of 20 min. (b) Representative recording from a single 
gonadotrope showing the effects of the P2X receptor agonists ß, Y methylene ATP (100 µM) and a, ß- 
methylene ATP (100 pM), and the P2Y receptor agonist 2-methylthio ATP (100 pM). The stimulations 
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Figure 43. Concentration-response curves showing the maximal increase in [Ca2+]i (mean + SEM: n 
> 15 cells from 3-5 separate experiments) in response to ATP, ADP and UTP with the indicated 
concentrations in previously unstimulated aT3-1 cells. 
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The simultaneous addition of 100 µM ATP plus 100 pM UTP failed to elicit a stronger 
Cat+; response than either alone in normal gonadotropes or in aT3-1 cells (Figure 4-4). 
Pretreatment with ATP (100 µM, 4 min) considerably reduced the subsequent response 
to ATP or UTP and pretreatment with UTP similarly reduced subsequent responses to 
ATP or UTP (Figure 4-5), while the cells remained highly responsive to subsequent 
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Figure 4-4. No additive effect of ATP and UTP at the maximal concentration on [Ca2+]i. 
aT3-1 cells (left panel) and rat pituitary gonadotropes (right panel) were stimulated with ATP and 
UTP alone or in combination as indicated. The Figure shows pooled maximal increase in [Ca2+]i 
(mean ± SEM from z 35 aT3-1 cells and >_ 8 pituitary gonadotropes, respectively) in which the 
responses did not differ significantly from one another (p > 0.05, unpaired t-test). 
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Figure 4-5. Homologous and hcterologous desensitization of ATP and UTP effects in aT3-I 
cells. Cells were stimulated as indicated with ATP, UTP (both 100 µM) and GnRH (10 nM). Each 
panel shows the mean ± SEM of [Ca2+]i values in >_ 8 cells (from a single representative 
experiment). The resting [Ca2+]i was approximately 30 nM for all the experiments. 
(b) 
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Cloning and Sequencing 
In order to further study ATP receptors in pituitary cells, reverse transcription of total 
pituitary mRNA followed by PCR (i. e. RT-PCR) was performed to obtain fragments 
of cDNA encoding ATP receptors by using a pair of degenerate PCR primers (see page 
61 for sequence). These primers were designed, according to the first published mouse 
NG 108-15 neuroblastoma P2U (Lustig et al. 1993) and chicken brain P2Y (Webb et 
al. 1993) cDNA sequence data, to pick up both P2U and P2y receptors, if any. Only 
one DNA fragment was obtained in these experiments. Subsequent cloning and 
sequencing of this DNA fragment showed that it was 563 base-pairs in length (Figure 
4-6). Overall nucleotide homology to mouse NG108-15 neuroblastoma P2U was 93%, 

















This study has clearly demonstrated that gonadotropes are direct targets for ATP action. 
This interpretation is based upon intracellular Ca 2+ imaging experiments showing that: 
1) 82% of GnRH-responsive cells also respond to ATP; 2) ATP- and GnRH- 
responsive pituitary cells are not responsive to the other main hypothalamic releasing 
hormones; and 3) nucleotide triphosphates increase cytosolic Ca2+ in the GnRH- 
responsive gonadotrope-derived aT3-1 cell line (Windle et al. 1990, McArdle et al. 
1992) with a similar pharmacological profile to that observed in normal gonadotropes. 
This identification is further validated by the superfusion experiments which show ATP 
causes a significant luteinizing hormone release from pituitary cells (Chapter 5). The 
ATP-induced Cat+; response in gonadotropes is specific, since the Cat+; response is 
blocked by the ATP receptor antagonist suramin and among the nucleosides and 
nucleotides examined only ATP, ADP, UTP and UDP produce a significant response. 
Gonadotropes, however, are not the only target cells for ATP, since these constitute 
only 9% of pituitary cells in culture, whereas approximately 30% of rat pituitary cells 
are responsive to ATP. The identification of other ATP-responsive pituitary cells 
remains to be established. 
The present study has characterized the subtype of ATP receptor in normal 
gonadotropes and aT3-1 cells by examining the agonist potency and efficacy of 
nucleotides and analogues. The complete absence of Cat+i increase in cells stimulated 
with pt-methylene ATP and a, ß-methylene ATP is indicative of a non-Pa receptor. 
This is further supported by the observation that ATP-induced responses involve Ca2+ 
mobilization from intracellular pools, which is apparently distinct from the ligand-gated 
ion channels of P2X receptors (Bean 1992, Abbracchio & Burnstock 1994). As the 
efficacy of 2-methylthioATP, commonly considered to be the key agonist in the 
definition of P2Y receptors, is much less than that of ATP, and a, p-methylene ATP (a 
partial P2 -purinoceptor agonist) failed to produce any Cat+; response, the receptor 
responsible for the Cat+; response in gonadotropes and aT3-1 cells is distinct from the 
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classic P2Y receptor as well. Furthermore, UTP induced a Cat+; response with similar 
potency and efficacy to ATP and ADP. Thus, the ATP receptors in rat gonadotropes 
and aT3-1 cells exhibits the following rank-order of agonist potency and efficacy: - 
ATP = ADP = UTP > 2-methylthioATP » ß, y-methylene ATP / a, p-methylene ATP. 
This pattern appears to fit best into the P2U subtype (Dubyak 1991, Lustig et al. 1993) 
or the P2Y2-purinoceptor according to the recent suggested reclassification of 
purinoceptors (Fredholm et al. 1994, Abbracchio & Burnstock 1994), and is 
consistent with the findings of 'nucleotide receptor' in mixed pituitary cells in culture 
(Davidson et al. 1990). 
It has been reported that in some cell types, ATP receptors are heterogeneous and 
mediate different responses in the same biological system (Keppens 1993). Recently, 
two distinct receptors (P2Y and Peu) were found to co-exist in endothelial cells 
(Wilkinson et al. 1993, Motte et al. 1993), suggesting that ATP and UTP may have 
different binding sites in one cell type, i. e. ATP binds to both P2y and P2U and UTP 
binds to PZU. In gonadotropes and aT3-1 cells, ATP and UTP appear to be acting via 
common receptors because the effects of ATP and UTP together do not exceed those to 
either nucleotide alone (Figure 3b), as has been demonstrated in renal mesangial cells 
(Pfeilschifter 1990) and airway epithelial cells (Brown et al. 1991). This interpretation 
is supported by the cross-desensitization between ATP and UTP (Figure 4-5). This 
cross-desensitization is specific to the nucleotides in that neither pretreatment reduced 
subsequent responses to GnRH, and presumably reflects desensitization occurring at 
the level of a shared nucleotide receptor. 
The molecular cloning data in this study was limited. Nevertheless, they are supportive. 
The primers used for RT-PCR were degenerate to both P2Y1 and P2U purinoceptors but 
only one cDNA fragment was obtained. The very high similarity of this cDNA to the 
cloned mouse NG108-15 neuroblastoma P2U (Lustig et al. 1993) but not to the 
chicken brain P2Y (Webb et al. 1993) seems to indicate that P2U rather than P2Y 
receptors are predominantly expressed in the pituitary. The present cloning work will 
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be of benefit to allow further cloning of full length of cDNA encoding rat pituitary ATP 
receptors, as the obtained cDNA fragment is an ideal probe to screen a cDNA library. 
Indeed, an ATP receptor has been cloned from pituitary cells using this cDNA probe 
and the clone has also been expressed and functionally characterized as the Peu subtype 
(data not presented in the thesis). 
Collectively, these data indicate that the responses of gonadotropes and aT3-1 cells to 
these nucleotides are mediated by a single class of receptor pharmacologically 
characterized as the Peu subtype and clearly implicate ATP receptors in the regulation of 
anterior pituitary function. 
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Chapter 5. ATP RECEPTOR-MEDIATED LUTEINIZING HORMONE 
RELEASE FROM PITUITARY CELLS 
Introduction 
The experimental data described in the last chapter (Chapter 4) have clearly shown that 
ATP and UTP act on ATP receptors to provoke a rapid and dramatic increase in 
cytosolic Ca2+ in pituitary GnRH-responsive cells. Given the central importance of 
Ca2+ in the mediation of exocytotic gonadotropin release (Huckle & Conn 1988), this 
data suggests that the effect of P2U receptor occupancy on Ca2+ metabolism in 
gonadotropes may have an important role in the regulation of their activity. To address 
this question, the present study employed a superfusion system to examine the effect of 
extracellular nucleotides on the kinetics of luteinizing hormone secretion. 
Methods 
Pituitary glands from 4 week-old female Wistar rats were enzymatically dispersed and 
after 2 days in culture, cells were subject to superfusion experiments. 
Results 
GnRH was a very strong stimulator of LH release (Figures 5-la & 5-2). Addition of 
ATP and UTP (both 100 µM) also caused a robust (more than 14 fold) increase in the 
rate of LH release from a resting LH release of 125 ± 10 and 73.5 ±7 pg/min to a 
maximum of 1755 ± 484 and 1261 ± 226 pg/min respectively (Mean ± SE: n= 3) 
(Figure 5-1a). Repetitive stimulation with ATP and UTP (both 6 µM) produced 
corresponding repetitive increases in LH release (Figure 5-lb). The LH release 
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Figure 5-1. ATP and UTP-induced LH release from superfused rat pituitary cells. (a) Representative 
examples showing stimulation with ATP (100 AM), UTP (100 MM), GnRH (10 nM) or vehicle alone for 
5 min (indicated by the bar). (b) The effects of repetitive stimulation with ATP (6 MM), UTP (6 MM) or 
vehicle, each for 4 min (indicated by the bars). Each trace is representative recording from 3-4 separate 
experiments. 








Figure 5-2. Concentration-dependent stimulation of LH release. Superfused rat pituitary cells 
were stimulated with ligand (for 5 min), followed, 30 mies later, by a standard dose of the calcium 
ionophore A23187 (5 pM for 5 rains). The results shown indicate the total LH released during the 
10 min following ligand addition, as a percentage of the total LH released within the experimental 
period of 60 min (including the basal LH release during the 20 min before addition of the ligand, 
the release in response to both ligand and A23187 and the release between the two). The results 
were thus corrected for potential depletion of the releasable LH pool and for overall response 
differences between experiments. Each data point (mean ± SE) was derived from 2 experiments for 
GnRH and UDP and from 3 experiments for ATP and UTP. In the control group (n = 5), the 
"agonist" was either superfusion medium or thyrotropin-releasing hormone (0.1 or I nM). 
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effect was obtained with 1.5 µM UTP or 100 µM ATP and the EC5o value for UTP 
and ATP action was approximately 0.5 µM and 40 µM, respectively. The maximal 
effect of both ATP and UTP was similar, amounting to about 30% of the maximal 
GnRH response. In the Ca2+-free medium containing 50 µM EGTA, the maximal UTP 
(6 µM)-induced LH release rate was attenuated by approximately 25%. 
Addition of UDP (100 µM) caused a significant increase in LH release from superfused 
cells as well (Figure 5-3c). The EC5o value for UDP was approximately 3 pM with a 
maximal effect comparable to both UTP and ATP (Figure 5-2). 
Among other nucleosides and nucleotides examined, adenosine, AMP, CDP, CTP and 
UMP (all 100 µM) had no effect on LH release from the superfused pituitary cells, 
while ADP, GDP and GTP (all 100. tM) had only modest stimulatory effects (Figure 
5-3). The P2X receptor agonists ß, y-methylene ATP and a, ß-methylene ATP (both 100 
µM) did not stimulate LH release, and 2-methylthioATP (P2Y receptor agonist) had 
only a modest stimulatory effect (Figure 5-3d). 
The simultaneous application of UTP and ATP (both 100 . tM) to superfused rat 
pituitary cells, failed to elicit a greater LH release than that obtained with either 
nucleotides alone (Figure 5-4a). Pretreatment with 100 µM UTP for 5 min considerably 
reduced the subsequent LH release in response to UTP or ATP (both 100 µM) (Figure 
5-4b & 4c). 
Discussion 
In the mouse gonadotrope-derived aT3-1 cell line, ATP, ADP and UTP were found to 
be equipotent in eliciting an intracellular Ca2+ response (Chen et al. 1994b), while in 
superfused rat pituitary cells in primary culture, the following rank-order of potency in 
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Figure 5-3. Effects of nucleoside and nucleotides on LH release. Cells were stimulated as indicated 
with various compounds (all 100 µM) for 5 min. Fach panel shows representative recording from 2 
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Figure 5-4. Effects of ATP and UTP on LH release. (a) Cells were stimulated with ATP and UTP 
alone or in combination as indicated. 
Experiments and data analysis were performed as described in the 
legend of Figure 2. The figure shows the mean ± SE (n = 3: no significant differences between groups 
using an unpaired t-test). 
(b & c) Homologous and heterologous desensitization of LH release. Cells 
were stimulated as indicated with 
UTP, ATP (both 100 µM) and GnRH (10 nM). Panels b &c show 
representative recording from 
2 separate experiments. 
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both ATP and UTP, however, was similar. This appears to suggest gonadotrope ATP 
receptors have high affinity for UTP. It is possible, however, that extracellular ATP 
may be preferentially subject to rapid degradation by ectoATPases or ecto- 
nucleotidases, resulting in a requirement for a high concentration of ATP in order to 
activate its receptor. 
The overall pharmacological profile for nucleotide actions in mediating LH release from 
superfused rat pituitary cells is strikingly similar to that revealed by the Ca 2+ imaging 
study at a single cell level (Chapter 4). This includes: - 1) the P2x receptor agonists ß, y- 
methylene ATP and a, ß-methylene ATP (both 100. tM) did not stimulate LH release, 
and 2-methylthioATP (P2y receptor agonist) had only a modest stimulatory effect, 
indicating neither typical P2X nor typical P2Y receptors are involved (Burnstock & 
Kennedy 1985, Gordon 1986, Dubyak 1991); 2) UTP was found to be more potent 
than ATP in stimulating LH release but the maximal effect was comparable, suggesting 
that the P2U subtype of ATP receptors is responsible for stimulation of LH release; 3) 
removal of extracellular Ca 2+ only attenuated the maximal UTP-induced LH release rate 
by - 25%, indicating that the UTP-provoked LH release is not entirely dependent on 
extracellular Ca2+ and thus implying activation of intracellular Ca2* mobilization; and 4) 
ATP and UTP at the maximal concentration had no additive effects on LH release and 
the heterologous desensitization between UTP and ATP occurred, suggesting that ATP 
and UTP act on a single class of ATP receptor in gonadotropes. As illustrated in Figure 
4- lb, the desensitization is reversible and seems to be rapidly overcome within a matter 
of an hour following ligand washout. 
These results, together with the Ca2+ and molecular cloning data described in Chapter 
4, have firmly established that gonadotropes are direct targets for extracellular 
nucleotides through a single class of ATP receptors characterized as the Peu subtype (or 
P2Y2 subtype as recently suggested (Abbracchio & Burnstock 1994)). Activation of 
these receptors leads to a significant increase in the rate of gonadotropin release. This 
data further reinforces the idea that the pituitary ATP receptors play an important - 
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presumably modulatory - role in the regulation of pituitary gonadotrope. 
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Chapter 6. ATP RECEPTOR-MEDIATED INTRACELLULAR 
RESPONSES IN GONADOTROPE-DERIVED aT3-1 CELLS 
Introduction 
ATP and other nucleotides act on a large and diverse family of P2 purinoceptors 
(Burnstock 1986, Gordon 1986), four of which have recently been cloned (Lustig et 
al. 1993, Webb et al. 1993, Brake et al. 1994, Valera et al. 1994). This receptor 
family can be divided into two distinct classes, the first being ligand-gated ion channels 
(P2x receptors) and the second consisting of G protein-coupled receptors (P2Y, P2U, 
P2T and P2D). Activation of the latter receptor group has been shown to lead to a 
complex signal transduction cascade involving inositol phosphate accumulation, Ca2+ 
mobilization, changes in cAMP production and activation of phospholipase A2. 
The data from this study have demonstrated that ATP increases intracellular Ca2+ 
concentration in a subpopulation of rat pituitary cells and we have identified 
gonadotropes as one of the target cells for ATP action via ATP receptors of the P2U 
subtype. Activation of this receptor causes a significant release of luteinizing hormone 
from superfused rat pituitary cells. In order to elucidate the possible signal transduction 
mechanisms subserving ATP actions in gonadotropes, the present study was to 
examine intracellular events other than inositol phosphate accumulation (which has 
already been well studied in pituitary cells (Davidson et al. 1990)) in response to ATP 
in a gonadotrope-derived aT3-1 cells bearing P2U receptors similar to those found on 
gonadotropes (Chen et a!. 1994c). 
Methods 
aT3-1 cells were cultured in 24-well culture plates for cAMP and cOMP assays or in 
75 cm2 culture flasks for Western immunoblotting of protein kinase C. For calcium ion 
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imaging at the single cell level, aT3-1 cells were harvested by trypsinization and then 
incubated for 2 days on 22 mm diameter glass coverslips. Cells were exposed to ligand 
by rapidly pipetting 2.5 ml of medium containing stimuli into the recording chamber 
which was maintained at approximately 0.5 ml by means of an aspiration tube 
positioned 2 mm above the coverslip. Cells with a clear intracellular Ca2+ response (i. e. 
those in which stimulation at least doubled the [Ca2+]i) were defined as 'ligand- 
responsive' and used to generate the data shown. In the present experimental condition, 
approximately 65% of aT3-1 cells were found to be ATP- or UTP (both 100 p. M)- 
responsive and more than 90% of the cells were GnRH (10 nM)-sensitive. Ca2+-free 
solution was made by omitting CaCl2 and adding 0.05 mM EGTA to Ca2+ buffer 
buffer. All experiments were repeated on at least three occasions and data shown are 
either from a single representative experiment or are pooled from multiple experiments 
as described. Means ± SE are given throughout. Paired or unpaired t-tests were 
performed where appropriate. 
Results 
Intracellular Ca 2+ signalling 
The addition of 100 µM ATP to fura-2 loaded aT3-1 cells produced a biphasic 
cytosolic Ca2+ response: a transient increase (spike) in [Ca2+]; from a resting [Ca2+]i of 
36 ± 0.4 nM to a maximum [Ca2+]; of 297 ± 27 nM (Mean ± SE: n= 26 cells of 3 
separate experiments) followed by a small plateau lasting for about 4 minutes (Figure 
6-1). The basal level of [Ca2+]1 in aT3-1 cells was similar to that reported by others 
who used the similar methodology (McArdle et al. 1992, Anderson et al. 1992). The 
intracellular Ca2+ response was relatively rapid and reached the peak between 4- 17 sec 
(mean =8 sec: n= 26 cells) after addition of ATP. Equimolar concentrations of UTP 










Figure 6-1. Intracellular Ca2+ increase in response to ATP in ccT3-1 cells. The trace shown is pooled from 
9 single cells in one representative experiment (mean ± SE). Addition of buffer alone or buffer containing 




In the absence of extracellular Cat+, ATP (100 . tM) produced a Ca 2+ spike, rising from 
19 ±1 nM to 266 ± 15 nM (n = 46 cells of 4 separate experiments) - the amplitude only 
slightly attenuated from that seen in Cat+-containing buffer (from 34 ±2 nM to 306 ± 
20 nM: n= 41 cells of 4 separate experiments). The second (plateau phase) of the Cat+i 
response was abolished, however, with [Caz+]; returning to baseline within 
approximately 1 minute (Figures 6-2a & 6-2b). Removal of extracellular Ca2+ after 
ATP stimulation rapidly reduced [Ca2+]i to basal levels (Figure 6-2c) and subsequent 
reintroduction of extracellular Cat+, returned [Ca2+]i to plateau levels comparable to the 
second phase of Cat+i response to ATP in Cat+-containing buffer (Figure 6-2d). The 
addition of antagonists of high voltage-sensitive Ca2+ channels such as cadmium (200 
. tM) and nifedipine (10 . LM), but not nickel (200 µM) (an antagonist of low voltage- 
sensitive calcium channels), to ATP-stimulated (M-1 cells in plateau phase rapidly 
reduced [Ca2+]; almost to the resting levels (Figures 6-2e & 6-2f). To further examine 
the involvement of voltage-sensitive Ca2+ channels in the second phase of the ATP- 
induced Ca2+ response, aT3-1 cells were depolarized by 40 mM of KCI. Subsequent 
stimulation with ATP produced an isolated Ca2+ spike (Figure 6-3), comparable to that 
seen under normal conditions. 
To examine which intracellular Ca2+ pools ATP mobilizes, aT3-1 cells were stimulated 
with both ATP and GnRH in Ca2+-free buffer. ATP (100 pM) reduced the subsequent 
Cat+; response to GnRH (10 nM) by approximately 50% (56 ±8% from 4 separate 
experiments; Figures 6-4a & 6-4b) and 10 nM GnRH abolished the subsequent Cat+i 
response to 100 µM ATP (Figures 6-4c & 6-4d). Pretreatment with thapsigargin (1 
µM), an endoplasmic reticular Cat+-ATPase inhibitor, caused a slow increase in 
[Ca2+]i and inhibited the subsequent maximal Cat+; response to Al? by approximately 
60% (63 ±4% from 3 separate experiments; Figure 6-5). Pretreatment with ryanodine 
(1 - 50 µM for 5 min), a blocker of intracellular Ca2+ release in some types of cell, 
however, had no effect on either basal levels of [Ca2+]; or ATP- and GnRH-induced 
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Figure 6-2. The effect of extracellular Ca2+ on the ATP-induced 
Cat+i increase in aT3-1 cells. (a & b) The 
cells were stimulated with 
ATP in Cat+-containing buffer (a) and in Ca2+-free buffer containing 0.05 mM 
EGTA (b). (c) Cat+-containing buffer was exchanged 
for Ca2+-free buffer after aT3-1 cells had been stimulated 
with ATP. (d) Ca2+-free 
buffer was exchanged for Cat+-containing buffer after aT3-1 cells had been stimulated 
with ATP. (e & f) 
200 pM of Ni2+ or Cd2+ and 10 pM of nifedipine was introduced after aT3-l cells had been 
stimulated with 
ATP. Each trace is pooled from >_ 7 single cells in one separate representative experiment (mean 
± SE). Buffer changes and ligand additions 
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Figure 6-3. The effect of cell membrane depolarization on the ATP-induced Cat+i response in 
aT3-1 cells. (a) Intracellular Ca2+ increase in response to depolarization by KCI. (b) Cells were 
depolarized with KCl and subsequently challenged with ATP. Each trace is pooled from >5 single 
cells in one separate representative experiment (mean ± SE) and applications of agents are indicated 
by the bars. 
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Figure 6-4. Extracellular ATP releases Ca2+ from GnRH-sensitive Ca2+ pools in CM-1 cells. 
Each trace is pooled from >6 single cells in one separate representative experiment (mean ± SE). 
The applications of Ca2+-free buffer containing 0.05 mM EGTA and ligands are indicated by the 
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Figure 6-5. Extracellular ATP mobilizes Ca2+ from thapsigargin-sensitive Ca2+ pools in aT3-1 
cells. Each trace is pooled from >_ 8 single cells in one separate representative experiment (mean ± 
SE). The applications of Ca2+-free buffer containing 0.05 mM EGTA and ligands are indicated by 
the bar and the arrow. 
Calcium-free buffer 
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Phosphoinositide-specific PLC is believed to play a central role in the inositol 
phosphate signalling system and, thus, it was interesting to examine whether this 
enzyme was involved in the ATP-induced Cat+1 response in aT3-1 cells. U73122, a 
specific inhibitor of PLC (Smallridge et al. 1992), was used and experiments were 
performed in Ca2+-free medium to confine the response to Ca2+ release from 
intracellular Ca2+ stores. Pretreatment with U73122 (3 PM) significantly increased the 
time for Cat+1 elevation from the basal to the peak in response to ATP (6.5 ± 0.3 s of 
the control from 54 cells of 4 separate experiments vs 12.0 ± 0.5 s from 46 U73122- 
pretreated cells of 4 separate experiments: P<0.01), accompanied by a reduction of 
the peak [Ca2+]; by approximately 35% (38 ±3% from 4 separate experiments; Figure 
6-6). 
Pretreatment of aT3-1 cells with 200 ng/ml PTX for 12-18 hrs had no effect on ATP- 
induced Cat+i responses. 
Involvement of CAMP and cGMP signalling 
To investigate whether the CAMP and cGMP signalling systems were involved in the 
Peu receptor-mediated intracellular responses, aT3-1 cells were challenged with 100 
µM of ATP or UTP for 10 or 30 min. No significant increase in the CAMP and cGMP 
concentrations was observed (Figures 6-7a & 6-8a). Since the turnover of these cyclic 
nucleotides is rapid, it is possible that a small increase in CAMP or cGMP might not be 
detected. Cells were therefore pretreated with the phosphodiesterase inhibitor IBMX 
(0.25 mM) to block the degradation of CAMP and cGMP. Again, no significant 
increases in cAMP and cGMP accumulations were induced by the treatment with Al? 
or UTP (Figures 6-7a & 6-8a). Although ATP/U TP on their own had no obvious effect 
on cAMP/cGMP signalling systems, they might exert modulatory effect on agonist- 
stimulated cAMP/cGMP responses. To assess this possibility, cT3-1 cells were 
stimulated with forskolin, pituitary adenylate cyclase-activating polypeptide 38 
(PACAP38) (McArdle et al. 1994) and C-type natriuretic peptide (CNP) (McArdle et 
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Figure 6-6. The effect of U73122 on ATP-induced Cat+i response in (M-1 cells. U73122 
was dissolved in ethanol and diluted in 
Ca2+-free buffer and the final concentration of ethanol 
was 0.4%, which had no apparent effect on [Ca2+]i as shown in the trace (a). Each trace is 
pooled from >_ 7 single cells in one separate representative experiment 
(mean ± SE), and 
applications of Ca2+-free buffer containing 
0.05 mM EGTA and ligands are indicated by the 
bar and the arrow. 
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Figure 6-7. No significant effects of activation of ATP receptors on cAMP signalling systems in 
aT3-1 cells. Cells were preincubated in 0.25 ml of BSS with 0 or 0.25 mM 3-isobutyl-l- 
methylxanthine (IBMX) at 37°C for 10 min, and stimulated with ATP (100 AM), UTP (100 AM), 
forskolin (2 AM) and PACAP38 (10 nM) alone or in combination as indicated for 10 or 30 min in the 
absence or presence of IBMX. Values are mean ± SE of 3 independent experiments in triplicate. 
paired t-test was used and no significant difference (P > 0.05) was found between the relevant groups. 
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Figure 6-8. No significant effects of activation of ATP receptors on cGMP signalling systems in 
aT3-1 cells. Cells were preincubated in 0.25 ml of BSS with 0 or 0.25 mM 3-isobutyl-l- 
methylxanthine (IBMX) at 37°C for 10 min, and stimulated with ATP (100 PM), UTP (100 p. M) and 
CNP (10 nM) alone or in combination as indicated for 10 or 30 min in the absence or presence of 
IBMX. Values are mean ± SE of 3 independent experiments in triplicate. Paired t-test was used and 
no significant difference (P > 0.05) was found between the relevant groups. 
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al. 1993) alone or in combination with UTP. No significant effect of UTP was 
observed on forskolin- and PACAP38-induced cAMP accumulation and on CNP- 
induced cGMP accumulation in the absence or presence of IBMX (Figures 6-7b & 6- 
8b). 
Translocation of PKC 
Hormonal stimulation of numerous cell types, including gonadotropes (Hirota et al. 
1985, Naor et al. 1985, McArdle & Conn 1986), has been shown to alter the 
subcellular distribution of PKC, increasing enzyme activity and immunoreactivity in the 
particulate fraction of cell homogenate with concomitant reduction in the cytosol, and 
this redistribution is thought to indicate activation. In aT3-1 cells, GnRH has been 
shown to increase PKC translocation to the membrane (Horn et al. 1991) and three 
isoforms of PKC (e, ý and a) have been shown to be expressed in aT3-1 cells 
(Johnson et al. 1993). To assess whether activation of P2U receptors in aT3-1 cells 
could cause PKC translocation, cells were stimulated with the slowly hydrolysable 
ATP analogue ATPyS (100. tM) and PKC determined by Western immunoblotting 
against individual PKC isoforms e, C and a. PKCa at - 87 KDa was detected in the 
cytosol fraction but not the particulate fraction in unstimulated cells and ATP1S- 
stimulated cells (Figure 6-9a). PKCC at -- 80 KDa was detected in both cytosol and 
particulate fractions but ATPyS did not cause any appreciable redistribution of this 
isozyme (Figure 6-9b). Stimulation with ATPyS, however, produced a modest but 
significant increase in the proportion of PKCe (at - 91 KDa) in the particulate fraction 
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Figure 6-9. ATP receptor-mediated activation of PKC in aT3-1 cells. (a - c) Representative 
Western immunoblots show immunoreactivity of the cytosol (C) and particulate (P) fractions of aT3- 
1 cells with subtype-specific antibodies to PKCa, C and e, respectively. (d) Histograms show the 
relative intensity of bands in the particulate 
fraction immunoreactive to the PKCc antibody. Values 
are mean ± SE of three separate experiments. *, P<0.01 in comparison to the control. Cells were 
treated with stimuli for 10 min and the final concentrations of DMSO (as control), GnRH and ATP'yS 
were 0.006%, 100 nM and 100 µM, respectively. 40 µg of total protein were loaded into each lane. 
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Discussion 
The data in Chapter 4 have shown that ATP causes an increase in [Ca2+]; via P2U 
purinoceptors in rat gonadotropes in primary culture and in gonadotrope-derived 0 3-1 
cells. The present data further show that the ATP-induced Cat+i response in aT3-1 
cells consists of two distinct phases: - a spike followed by a small plateau. The first 
phase of Cat+i response is due to Ca2+ release from the intracellular Ca2+ pools. 
Pretreatment with ATP in Ca2+-free medium significantly reduced the subsequent Ca2+ 
response to GnRH and, similarly, pretreatment with GnRH eliminated the subsequent 
Ca2+ elevation in response to ATP indicates that both ATP and GnRH share a common 
Ca2+ pool in aT3-1 cells. Furthermore, this Ca2+ pool is sensitive to thapsigargin but 
not ryanodine, since pretreatment with the former (1 µM) significantly reduced the 
ATP-induced increase in [Ca2+]i. These observations are in line with the previous 
findings that GnRH mobilizes Ca2+ from the thapsigargin-sensitive Ca2+ pool in both 
rat gonadotropes and aT3-1 cells (McArdle & Poch 1992, Merelli et al. 1992). 
It has been well documented that activation of P2U receptors causes an increase in 
inositol phosphate turnover and mobilization of intracellular Ca2+ (Dubyak 1991). The 
present study showed that the specific PLC inhibitor, U73122, was able to inhibit the 
Ca2+ mobilization in response to ATP and, thus, provides a direct demonstration for 
involvement of PLC in the coupling of the P2, receptor to the IP/Ca2+ signalling 
system. In addition, the lack of effect of PTX on the ATP-induced Cat+i increase 
indicates that Caz+ mobilization by ATP in aT3-1 cells is mediated by a PTX- 
insensitive G-protein, which is similar to GnRH receptors that are also linked to PTX- 
insensitive G (probably Gq and G11) (Hsieh & Martin 1992). This is in agreement 
with the data obtained from cultured sheep pituitary cells (Davidson et al. 1990) but 
differs from the findings from aortic endothelial cells, where P2U receptors were found 
to be coupled to a PTX-sensitive G-protein (Motte et al. 1993). 
Removal of extracellular Ca2+ has little effect upon the spike of ATP-induced Ca2+ 
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response but abolishes the second phase (plateau) of the response, indicating that Ca2+ 
influx is largely responsible for the plateau. The blockade of this Ca2+ influx by Cd2* 
and nifedipine and by KCl-induced membrane depolarization suggests that during the 
plateau phase, ATP stimulates Ca2+ entry via voltage-sensitive Ca2+ channels. aT3-1 
cells express both low and high voltage-gated Ca2+ channels (Bosma & Hille 1992) but 
the lack of effect of Ni2+ on Ca2+ elevation indicates the predominant involvement of a 
high voltage-sensitive Caz+ channel in ATP-induced Ca2+ influx. The ATP-induced 
Ca2+ metabolism in aT3-1 cells, thus, resembles that provoked by GnRH, although the 
amplitude of an increase in [Ca2+]; and, in particular, the plateau phase in response to 
ATP is smaller than that induced by GnRH (Merelli et al. 1992, McArdle et aL 1992). 
The mechanisms for triggering the Ca2+ influx, however, is not clear, although many 
theories have been proposed for the receptors which are coupled to IP/Ca2+ signalling, 
such as the capacitative model and receptor-activated Caz+ influx (Putney Jr & Bird 
1993). 
In addition to the IP/Ca2+ signalling, G protein-linked ATP receptors have also been 
shown to utilize or interact with other signalling systems in some types of cell, which 
may occur directly or as a consequence of activation of the IP/Caz+ system. Inhibition 
of agonist-stimulated accumulation of cAMP by ATP have been observed in NG 108-15 
neuroblastoma cells (Snider et al. 1984) and C6-2B glioma cells (Debernardi et al. 
1991), and is thought to be caused by the increased cytosolic Cat+, which functions as 
a negative allosteric effector to reduce adenylyl cyclase activity (Steer & Levitzki 1975, 
Debernardi et al. 1993b). In other cells such as myocytes (Yamada et al. 1992), 
hepatocytes (Okajima et al. 1987), FRTL-5 thyroid cells (Okajima et al. 1989), renal 
LLC-PK1 cells (Anderson et al. 1991) and sertoli cells (Filippini et al. 1994), direct 
coupling of ATP receptors to adenylyl cyclase has been suggested for the inhibitory 
effect on cAMP generation. Apart from the inhibitory effect, ATP receptors might 
directly or indirectly increase cAMP production, as observed in aortic smooth muscle 
cells (Tada et al. 1992), Swiss 3T3 and 3T6 fibroblasts (Huang et al. 1991) and 
pTX-treated FRTL-5 thyroid cells (Sato et al. 1992). In addition to CAMP, 
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involvement of phospholipase D (PLD) and cGMP in the ATP receptor-coupled signal 
transduction has also been reported in some cell types (Snider et al. 1984, Martin & 
Michaelis 1989, Purkiss et at 1993). However, the present data show that in aT3-1 
cells activation of ATP receptors did not exhibit any significant effects on cAMP and 
cGMP generation and on forskolin- and PACAP38-induced cAMP accumulation and 
CNP-induced cGMP accumulation. 
As ATP is capable of inducing inositol phosphate accumulation and an increase in 
[Ca2+)1 in many cell types, it has long been assumed that agonist occupancy of G 
protein-coupled ATP receptors, such as the Peu subtype, would lead to activation of 
PKC. Such activation, however, has not yet been directly demonstrated (Boarder et at 
1995). In the present experimental model using the Western immunoblotting with 
isozyme specific antibodies to examine PKC translocation in aT3-1 cells, we have been 
able to show that addition of ATPyS can cause modest but significant redistribution of 
PKCE. The present data hence has not only provided, to my knowledge, the first direct 
demonstration of PKC translocation by ATP receptors (P2u subtype), but also implicate 
the potential importance of extracellular nucleotides in the regulation of gonadotrope 
function. 
The PKC family consists of three groups: - conventional PKCs (cPKCa4ßI, P11, and y), 
which are activated by Cat+, diacylglycerol and phospholipid; novel PKCs (nPKC6, e, 
t, and 0), which are Cat+-independent and DAG-and phospholipid-activated enzymes; 
and atypical PKCs (aPKCC and X) (for review see (Nishizuka 1992)). Several isoforms 
of PKC (a, ß, 8, c and 0) are present in rat pituitary cells (Garcia-Navarro et al. 1994) 
and PKCßII has been located in rat gonadotropes (Ohmichi et at 1992). Activation of 
this enzyme family has been suggested to play mediatory roles in various cellular 
responses of gonadotropes (Counis & Jutisz 1991, Stojilkovic et al. 1994) although 
the precise roles have not been established in these cells (McArdle et at 1987). In 
gonadotrope-derived aT3-1 cells, inmmunoreactivity to PKCa, E and C (Johnson et at 
1993) and transcripts of PKC1 (Shraga-Levine et at 1994) have been detected. GnRH 
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induces an increase in PKCß gene expression in these cells (Shraga-Levine et al. 
1994), but, surprisingly, only non-conventional PKCe and ý but not conventional 
PKCa are translocated to the particulate fraction by GnRH (Kratzmeier et al. 1995). 
Similarly, the present data show that activation of ATP receptors also causes PKCE (but 
not a and ;) translocation to the particulate fraction. The mechanism(s) underlying and 
the consequence of such translocation are, however, unknown at present. One feature 
of ATP receptors in aT3-1 cells is occurrence of rapid desensitization after agonist 
occupancy (Chen et al. 1994c) and this might be associated with activation of PKCc, 
as such activation has been shown to mediate feedback inhibition of PLC in rat 
basophilic RBL-2H3 cells (Ozawa et al. 1993). 
Together, these data greatly strengthen the suggestion of a role for extracellular 
nucleotides in regulation or modulation of gonadotrope function. 
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Chapter 7. EXOCYTOTIC RELEASE OF ATP FROM PITUITARY 
CELLS 
Introduction 
The data described in previous chapters strongly suggest that pituitary ATP receptors 
may play an important role in the regulation of pituitary function. This suggestion raise 
the question of the source of extracellular nucleotides. It has long been known that the 
concentration of intracellular ATP is very high (at mM level) and that in many secretory 
cells, such as adrenal medulla cells (Smith 1968, Rojas et at 1985), pancreatic B-cells 
(Sussman & Leitner 1977), platelets (Born 1958), mast cells (Osipchuk & Cahalan 
1992) and neurons (Fried 1980, Volknandt & Zimmermann 1986), secretory granules 
and vesicles contain ATP and other nucleotides in addition to specific transmitters and 
hormones. As far as pituitary cells were concerned, the local release of nucleotides may 
occur in conjunction with pituitary hormone secretion since the pituitary gland contains 
many secretory cells. The present study was to test this hypothesis by examining the 
real-time dynamic ATP release in an in vitro calcium ionophore-induced exocytosis 
model. 
Methods 
pituitary glands from adult Wistar rats of both sexes were enzymatically dispersed and 
approximately 2x 105 cells were plated out in a plastic vial with a2 cm2 surface area in 
M199 culture medium. After 2 days in culture, real-time dynamic bioluminescence 
measurements of ATP release on attached cells was performed as described (Chapter 2: 
page x). Under the present set-up condition, the light was linearly related to ATP 
concentrations in the reaction mixture between 5x 10-12 and 5x 10-8 M. Because ATP 
was determined by the bioluminescent method, a non-fluorescent form of calcium 
ionophore A23187, i. e. bromo-A23187 (Deber et al. 1985), was chosen to avoid 
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potential interference with the ATP assay. 
Results 
Addition of A23187 induced a significant release of ATP from cultured pituitary cells in 
a concentration-dependent manner, as indicated by increased luminescence (Figure 7- 
1). Compared to external ATP standards (0.005 nM - 10 nM), it was estimated that 20 
tM A23187 induced the release of 3.15 ± 0.9 pmol of ATP (n = 5) from approximately 
2x 105 primary rat pituitary cells plated out 48 hr previously. 
The simultaneous addition of 10 units of apyrase (an ATPase/ADPase for the reaction: 
ATP -+ AMP + 2Pi) with A23187 abolished the increase in emitted light, and when 
added after A23187 rapidly reduced the A23187-induced light increase (Figure 7-2). 
Removal of extracellular Ca2+ abolished A23187-induced ATP release but did not 
significantly affect the luciferase-luciferin reaction, since the application of external 
ATP still produced a comparable light signal to that in Cat+-containing medium (Figure 
7-3). 
Pretreatment with 20 tM A23187 for 28 min reduced the response to A23187 2 hours 









































Figure 7-2. Depletion of extracellular ATP by apyrase. Following the addition of 10 µL of buffer (B), 
cells were stimulated with 10 pL A23187 alone (final concentration 20 MM: Trace 1) or A23187 as 
above plus 10 units of apyrase (in 6 pL: Trace 3). In another experiment, 6 µL of buffer and 10 units of 
apyrase (in 6 µL) were introduced sequentially to A23187-stimulated pituitary cells (Trace 2). Emitted 
light was not recorded during addition of reagents, hence the gaps in trace 2. Each trace shows 
representative recording from 3 separate experiments. 










Figure 7-3. Dependency of A23187-induced ATP release on extracellular Ca2+. Following the 
addition of 10 µL of buffer (B), cells were stimulated with A23187 (final concentration: 20 µM) in 
either Cat+-containing medium (4 mM: Trace 1) or Ca2+-free medium containing 50 pM EGTA (Trace 
2). The prompt response to the addition of external ATP in Cat+-fase medium (final concentration: 20 
nM) after 25 minutes (trace 2) confirmed the integrity of the assay system. Each trace shows 
representative recording from 4 separate experiments. 











Figure 7-4. Desensitization of A23187 effect on ATP release. Following the addition of buffer (B), 
cells were stimulated with 10 µL of A23187 (final concentration: 20 µM: Trace 1), then thoroughly 
washed and incubated in cell culture medium containing 20 mM HEPES at 37°C for 2 hours. The 
identical procedure was then repeated on the same cells (Trace 2). Each trace shows representative 
recording from 4 separate experiments. 
5 10 15 20 25 30 
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Discussion 
The calcium ionophore-induced increase in light output in this study clearly 
demonstrates that substantial amount of ATP can be released from pituitary cells. The 
bioluminescence assay with luciferin and luciferase has been found very specific to 
ATP (Strehler & McElroy 1957, White 1978). The identification of ATP in the present 
experimental model is confirmed by the ability of apyrase to eliminate the increase in 
emitted luminescence (Figure 7-2). 
As illustrated in Figure 7-1, the rate of increase in relative light intensity in response to 
A23187 was slower than that seen after the addition of exogenous ATP to the reaction 
mixture. These different profiles are likely to indicate occurrence of exocytotic secretion 
of ATP induced by the calcium ionophore. The exocytotic release of ATP is also 
implied by the data of Cat+-dependency (Figure 7-3) and the observed homologous 
desensitization (Figure 7-4). The latter presumably reflects depletion of secretory 
granule pools. 
The obtained ATP release data imply a possible paracrine and/or autocrine mechanism 
by which the extracellular nucleotides may exert their effects on pituitary cells. Whether 
ATP is stored and released in its own right or co-stored and co-released with pituitary 
hormones is not known but the latter is favored by the findings from other cell types 
such as adrenal chromaffin cells (Douglas & Poisner 1966, Smith 1968) and pancreatic 
B-cells (Sussman & Leitner 1977). The concentration of ATP in pituitary secretory 
granules and their possible co-existence with other nucleotides remains to be 
determined. 
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Chapter 8. OVERALL SUMMARY AND CONCLUDING REMARKS 
ATP is well known for its metabolic function, namely, as the main chemical energy 
supplier for numerous cellular reactions. Work in the past two decades, however, has 
unveiled another important role for this molecule: - it is also a transmitter for 
communication between cells. By acting on its own large receptor family (P2 
purinoceptors), ATP has been implicated in a variety of biological processes including 
neurotransmission, cardiovascular function, platelet aggregation, secretion of insulin 
and surfactant, immune response and cell growth. The studies described in this thesis 
were undertaken to investigate a possible transmitter role for extracellular ATP in the 
neuroendocrine system. 
By using calcium imaging at a single cell level, this study showed that exogenously 
applied ATP was able to provoke a rapid increase in [Ca2+); in a subset (- 40%) of 
cultured rat hypothalamic neurons. This intracellular Ca2+ response was highly specific 
and mediated by ATP receptors of the P2X subtype. Activation of these receptors 
resulted in influx of Ca2+ largely through high voltage-gated Cat channels and Al? 
hydrolysis was not required for such activation. These findings indicate that ATP may 
act as an excitatory neurotransmitter to influence the hypothalamic function. Indeed, 
there is some in vivo evidence to support this. Adrenergic receptor antagonists by 
systemic and intracerebroventricular delivery or direct injection into the supraoptic 
nucleus (SON) failed to block Al-induced excitation of SON vasopressin cells 
(receiving a direct and excitatory noradrenergic input from the ventrolateral medulla Al 
cell group) (Day et al. 1990), while local application of ATP and ac, ß-methylene ATP 
stimulated putative vasopressin cells an effect which was blocked by the ATP receptor 
antagonist suramin (Day et al. 1993). No electrophysiological recordings have been 
made in this study and therefore the nature of these ATP receptors, such as ion 
selectivity and channel kinetics, is still unknown. Furthermore the identity of ATP 
receptor-bearing cells and possible functional roles associated with ATP 
neurotransmission remain to be determined. 
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Previous work has shown that ATP and UTP, acting on "nucleotide receptors" (now 
called P2U receptors), stimulate inositol phosphate accumulation and 45Ca2+ efflux in 
mixed pituitary cell population (Davidson, 1990 #264). The data from the current 
studies indicate that approximately one third of rat pituitary cells respond to ATP and 
that gonadotropes represent a specific population of ATP-targeting cells via a single 
class of ATP receptors characterized as the Peu subtype. Owing to the small number of 
gonadotropes in the whole population of pituitary cells, it is very difficult to obtain 
relatively pure gonadotrope cell cultures. However, the gonadotrope-derived aT3-1 
cells were also used in these studies and were shown to bear the P2U receptors similar 
to those on gonadotropes, rendering an ideal alternative model to examine the signal 
transduction mechanisms subserving the gonadotrope ATP receptors. Experiments with 
these cells showed that activation of ATP receptors had no apparent effects on the 
CAMP and cGMP signalling systems but produced a biphasic cytosolic Ca2+ increase. 
The Ca2+ response was mediated by a pertussis toxin-insensitive and phospholipase C- 
coupled G-protein. Mobilization of intracellular Ca2+ from GnRH- and thapsigargin- 
sensitive Ca2+ pools and Ca2+ influx through high voltage-sensitive Ca2+ channels 
were responsible for the observed two phases of Ca2+ response. 
Activation of G protein-coupled ATP receptors, such as the P2U subtype, has been 
assumed to stimulate PKC but this assumption has not previously been directly 
demonstrated. Using Western immunoblotting to examine PKC translocation, I have 
been able to provide the first direct demonstration that agonist occupancy of G-protein 
linked ATP receptors can cause translocation of PKC (of the isozyme e in aT3-1 cells). 
At the `physiological' level I have been able to link the intracellular Ca2+ response of 
gonadotropes to ATP with the secretory mechanism in these, cells and have been able to 
demonstrate that extracellular ATP can achieve a significant release of luteinizing 
hormone from superfused rat pituitary cells. As gonadotropes only constitute a small 
proportion of pituitary cells (9% found in this study), the identification of other ATP- 
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responsive pituitary cells remains to be established. Some preliminary data obtained 
from the on-going study (not presented in this thesis) has shown that lactotropes are 
also direct target cells for ATP action. 
The bioluminescence measurements with luciferin-luciferase revealed that a substantial 
amount of ATP (approximately 3 pmol of ATP released into a volume of 200 µl over 
30 min by -2x 105 cells in response to 20 µM A23187) can be exocytotically released 
from pituitary cells in primary culture. Considering that the inter-cellular gaps in the 
intact tissue are very small, the high concentration (at the p. M level) of ATP required for 
receptor activation could probably be achieved in vivo. How ATP is stored and 
released however has not yet been determined, but our data imply a possible paracrine 
and/or autocrine mechanism by which the extracellular nucleotides may exert their 
effects on pituitary cells. 
There can be little doubt from the data described that ATP receptors play a role in 
pituitary function. Pituitary hormone secretion is principally regulated by classic 
hypothalamo-hypophyseal factors including GRH, somatostatin, GnRH, CRH, 
vasopressin, oxytocin, TRH and dopamine. Hence, the obvious question is to what 
extent ATP and other nucleotides, acting on ATP receptors, may exert physiological 
effects on pituitary hormone secretion in vivo. Though at present there is no 
experimental data available to address this question, it appears unlikely that nucleotides 
would act in the same dramatic fashion as do the classic hypothalamo-hypophyseal 
factors. It is possible and more likely, however, that these nucleotides may function in 
a subtle way so that many pituitary activities could be influenced or modulated. ATP 
might interact with hypothalamo-hypophyseal factors in regulation of hormone 
secretion. It might be utilized as an autocrine and/or paracrine factor for cells in the 
same and/or different population(s) for communication and modulation of cell activity. 
ATP might even affect pituitary cell growth and differentiation. 
Overall, the studies in my dissertation strongly suggest that extracellular ATP and other 
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nucleotides play important roles in neuroendocrine function and suggest that further 
investigation into the identification of yet-unknown nucleotide-targeting cells could 
provide important functional data on the local regulation of neuroendocrine systems. 
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